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Abstract 
Fish is a vital source of valuable omega-3 (n-3) fatty acids (FA) in the human diet. 
With declining commercial fisheries, aquaculture fish constitute a growing proportion 
of human consumption. Sustainable development of aquaculture requires that the fish 
feed used is not solely based on fish meal and oil (FO), but also contains increasing 
levels of vegetable oil (VO). The replacement of FO with VO influences FA 
composition in fish tissues by decreasing n-3 long-chain polyunsaturated fatty acids 
(LCPUFAs) and the nutritional value for humans. Accordingly, the last decade of 
salmonid research has focused on increasing the amount of n-3 LCPUFAs in fish fed 
VO diets e.g. addition of bioactive compounds. This thesis examined the potential 
effects of bioactive compounds on lipid metabolism in salmonids. 
Genes involved in transcriptional regulation, uptake, β-oxidation, elongation and 
desaturation were shown to be affected by addition of bioactive compounds in both in 
vivo and in vitro experiments. Effects on FA composition were also observed, but no 
clear effect on docosahexaenoic acid (DHA) content. 
The discrepancies between increased gene expression of target genes in the 
desaturation and elongation cascade and the actual lack of response in FA content of 
eicosapentaenoic acid and docosahexaenoic acid may be the result of a combination of 
feedback regulation and post-transcriptional regulation, such as RNA silencing through 
microRNA (miRNA) repression. 
This thesis describes the miRNA transcriptome in liver tissue of Atlantic salmon 
post-smoltification and the tissue distribution of selected miRNAs in nine different 
somatic tissues of juvenile Atlantic salmon (Salmo salar) for the first time. The results 
expand the number of known Atlantic salmon miRNAs and provide a framework for 
understanding the n-3 LCPUFA pathway in Atlantic salmon. 
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1 Introduction 
Gene expression deals with differences in expression of genes, as a response to 
external and/or internal stimuli, in which daily environmental influences and 
feeding habits play a crucial role. Atlantic salmon (Salmo salar L) and rainbow 
trout (Oncorhynchus mykiss) are among the most popular fish species in the 
Western diet and their content of n-3 long-chain polyunsaturated fatty acids 
(LCPUFA) is of great importance for human health.  
In this thesis, the underlying molecular regulation mechanisms of n-3 
LCPUFA biosynthesis were studied, with the emphasis on post-transcriptional 
regulation in salmonids. The aims were to contribute to future optimization of 
the content of n-3 LCPUFA in salmonids through enhanced activity of the 
desaturation and elongation pathway and to enable sustainable use of vegetable 
oils (VO) in aquaculture while maintaining the beneficial lipid composition for 
human consumption. 
1.1 Lipid metabolism in salmonids 
Lipids and fatty acids (FA), together with proteins, are the major 
macronutrients in the diet of salmonids (Leaver et al., 2008a; Tocher, 2003; 
Torstensen et al., 2000). They act as a source of essential FAs and energy, as 
well as functioning as a carrier of other lipid-soluble compounds such vitamins 
and pigments. 
Lipids are a diverse group of compounds that are classified depending on 
their insolubility in water. There are basically two classes of lipids – neutral 
and polar lipids. Neutral lipids primarily include triacylglycerols (TAG), 
diacylglycerols, monoacylglycerols and sterols, which mostly serve as storage 
and sources of energy. Neutral lipid composition, particularly TAG 
composition, reflects changes made in dietary FA composition (Torstensen et 
al., 2001; Lie et al., 1988). Polar lipids are mainly phospholipids (PL), which 
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are predominantly incorporated into membrane structures (Tocher, 1990; 
Tocher & Dick, 1990a). Phospholipids to some degree, also reflect the 
polyunsaturated fatty acid (PUFA) composition of the diet, but shorter dietary 
PUFA, such as α-linolenic acid (18:3n-3, ALA) and linoleic acid (18:2n-6, 
LA), are normally elongated and desaturated prior to incorporation into PL. 
1.1.1 Polyunsaturated fatty acids 
In PUFA, the position of the first double bond is important for the 
nomenclature. If the first double bond is present next to the third carbon atom 
from the methyl end of the carbon chain, the FA is classified as an n-3 FA, 
while if it is next to the sixth carbon atom, the FA is classified as an n-6 FA. 
Two PUFAs are essential in salmonids as in all vertebrates, namely ALA 
and LA. In salmonids, dietary LA can be metabolized to its longer chain 
derivate, arachidonic acid (ARA, 20:4 n-6), and ALA can be converted to 
eicosapentaenoic acid (EPA, 20:5n-3) and further on to docosahexaenoic acid 
(DHA, 22:6 n-3) through a series of desaturation and elongation steps. It has 
been shown that growth can be significantly improved in salmonids by 
inclusion of dietary n-3 LCPUFAs (reviewed in Tocher, 2010; Ruyter et al., 
2000).  
1.2 Aquaculture 
Aquaculture is one of the fastest-growing animal food-producing sectors and, 
in the next decade, the total production from both capture and aquaculture is 
expected to exceed that of beef, pork and poultry (FAO, 2012). Roughly 50% 
of fish for human consumption are now farmed and this portion will continue 
to grow (FAO, 2012; FAO, 2010). However, if aquaculture is to continue to 
expand, the availability of sustainable and quality aquafeeds must increase. 
Aquafeeds are generally used for feeding omnivorous fishes, carnivorous 
fishes and crustacean species. Fish living primarily on phytoplankton do not 
require any other forms of feeding and only use limited amounts of commercial 
aquafeed (FAO, 2006). 
Aquafeeds have traditionally been based on fish meal and fish oil (FO) with 
high levels of n-3 LCPUFAs from pelagic fisheries (Regost et al., 2004). The 
amount of FO consumed in the aquaculture sector has grown threefold since 
1992 and today 90% of all FO produced goes to aquafeeds (FAO, 2012; Tacon, 
2005). Accordingly, the development of aquaculture has been heavily 
dependent on the availability of FO. The global production of fishmeal and FO 
has remained stable or even shown a decline while aquaculture production has 
increased. It is therefore important to find a viable alternative to FO as the lipid 
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source in fish feed. Substantial efforts have been made to find alternative 
sustainable solutions, of which the use of vegetable oils (VO) as a replacement 
for FO in aquafeed formulations has been shown to be an accessible alternative 
(reviewed in Nasopoulou & Zabetakis, 2012; Tacon & Metian, 2008; Powell, 
2003).  
1.2.1 Effects of vegetable oils in salmonid culture 
Studies of Atlantic salmon have shown that VO can replace FO in fish feed to a 
large extent without compromising growth, flesh astaxanthin levels or 
mortality rate (Sanden et al., 2011; Torstensen et al., 2005b; Bell et al., 2003a; 
Rosenlund, 2001; Ruyter & Thomassen, 1999). The taste of salmon is known 
to vary depending on the composition of the salmon feed. Sensory analyses 
have shown that fillets from salmon fed a mixture of VO have roughly the 
same taste and aroma as fillets from salmon fed a diet including FO, but have a 
somewhat less characteristic marine taste (Sanden et al., 2011; Torstensen et 
al., 2005b). Similar results have been reported for rainbow trout, in which fillet 
pigmentation is highly affected by different VO dietary inclusion levels and 
shelf-life of the refrigerated product increases (Turchini et al., 2013b). 
 However, the tissue FA composition of fish has been shown to be highly 
sensitive to differences in diet lipid composition (Turchini et al., 2013b; 
Torstensen et al., 2009; Torstensen et al., 2004; Torstensen et al., 2000; Tocher 
& Dick, 1990a). The most severe effect from a human health perspective is the 
decreased nutritional value as a result of reduced fillet content of n-3 LCPUFA, 
e.g. EPA and DHA (Rosenlund, 2001). Major scientific efforts to find 
alternatives to FO and still maintain as high an n-3 LCPUFA content as 
possible in fish fillet have been undertaken (Turchini et al., 2013a; Turchini et 
al., 2013b; Mráz et al., 2012; Ruxton et al., 2005; Robin et al., 2003; Ackman, 
1996).  
Salmonids have the capacity to convert ALA to EPA and DHA, a capacity 
which is stimulated in fish fed VO compared with fish fed FO (Kjær et al., 
2008; Buzzi et al., 1996). According to Ruyter et al. (2000), the capacity for 
conversion of ALA to EPA and DHA is 20% lower in hepatocytes from 
Atlantic salmon fed FO than from Atlantic salmon fed linseed oil. Despite 
being quite efficient at converting ALA to EPA and DHA, in Atlantic salmon 
(Torstensen et al., 2004; Bell et al., 2003b) and rainbow trout (Thanuthong et 
al., 2011; Turchini et al., 2007b), the change from FO to VO formulation in 
aquafeed causes a total net reduction in fish body content of EPA and DHA.  
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1.2.2 Strategies to restore LCPUFA levels in salmonids 
Different strategies have been applied to achieve satisfactory nutritional levels 
of EPA and DHA in farmed fish fillets after reducing the amount of FO used in 
fish feed.  
 In order to ensure that the levels of saturated FAs (SAFAs), 
monounsaturated fatty acids (MUFAs) and PUFAs in VO-based feed are at 
roughly the same level as in FO-based feed, a mixture of linseed oil, 
rapeseed oil and palm oil can be used (instead of single VO) (Torstensen et 
al., 2005b).  
 By introducing a finishing diet period immediately preceding slaughter, the 
EPA and DHA content in the muscle can be increased (Mráz, 2012; 
Turchini et al., 2007a; Rosenlund, 2001). 
 Addition of bioactive compounds has been shown to promote the ability of 
fish to convert ALA to EPA and DHA (Trattner et al., 2008a; Kennedy et 
al., 2007a; Kleveland et al., 2006a).  
 Selective breeding for heritable traits associated with EPA and DHA 
composition has been evaluated (Berge et al., 2014; Berge et al., 2013; 
Leaver et al., 2011; Morais et al., 2011; Olesen et al., 2003; Gjedrem, 
1997).  
 
The focus in this thesis is on use of bioactive compounds as supplements to 
VO-based diets to possibly counteract the observed decrease in n-3 LCPUFA 
in fish tissues. In addition, transcriptional and post-transcriptional regulation of 
lipid metabolism were studied. As a first step, a screening of microRNA 
(miRNAs) in Atlantic salmon was carried out. The overall objective of this part 
of the work was to find an approach to interact with the lipid metabolism by 
manipulating the miRNAs, similarly to other therapeutics targeting miRNAs. 
By determining the miRNA status in Atlantic salmon, identifying their 
functions and finding an approach to manipulate these miRNAs, the aim was to 
open up for new possibilities for sustainable production of fish rich in n-3 
LCPUFA. 
1.3 Bioactive compounds 
Bioactive compounds are naturally occurring constituents present in small 
amounts in plant products and lipid-rich foods that provide health benefits 
beyond the basic nutritional value of the product (Kris-Etherton et al., 2002). 
Many of these substances affect lipid metabolism and/or exhibit antioxidative 
properties. A number of bioactive substances, e.g. sesamin, episesamin (ES), 
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tetradecylthioacetic acid (TTA) and lipoic acid (LPA), have been reported to 
affect lipid metabolism and/or FA composition in rainbow trout, Atlantic 
salmon and pacu (Piaractus mesopotamicus) (Trattner et al., 2008a; Moya-
Falcón et al., 2004).   
1.3.1 Sesamin 
Sesamin is an oil-soluble lignan found in sesame seed and oil. During the 
refining process of sesame oil, episesamin is formed from sesamin. Sesame 
lignans are well studied in mammals and are reported to have significant 
effects on lipid metabolism. They have been shown to increase β-oxidation 
(Jeng & Hou, 2005; Ashakumary et al., 1999), affect elongation and 
desaturation of FAs (Fujiyama-Fujiwara et al., 1995) and lower serum levels of 
triacylglycerols and cholesterol (Jeng & Hou, 2005; Kushiro et al., 2002; 
Kamal-Eldin et al., 2000). Ide et al. (2001) also showed that sesamin can 
decrease the hepatic activity and messenger RNA (mRNA) expression of 
enzymes involved in FA synthesis. The lipid-modulating effects of sesamin 
may be mediated via the activation of peroxisome proliferator-activated 
receptors (PPARs) and the inhibition of sterol regulatory element-binding 
protein-1 (SREBP-1) (Ide et al., 2004; Ide et al., 2003; Ashakumary et al., 
1999).  
Sesamin/episesamin and TTA have been shown to increase β-oxidation 
products and the levels of DHA in rainbow trout muscle (Trattner et al., 2008a) 
and to affect the expression of delta-5 fatty acid desaturase (Δ5FAD) and delta-
6 fatty acid desaturase (Δ6FAD), carnitine palmitoyl transferase 1 (CPT1), 
PPARα and PPARγ in Atlantic salmon hepatocytes (Trattner et al., 2008b). 
Kushiro et al. (2002) showed that sesamin is metabolized faster than 
episesamin in rat liver and that episesamin is more effective than sesamin in 
increasing the activity and gene expression of FA oxidation enzymes. Yasuda 
et al. (2012) showed a difference in metabolism of sesamin and episesamin in 
human liver microsomes, resulting in different biological effects. 
1.3.2 Lipoic acid 
Another bioactive compound of interest for fish feed is LPA. It is a potent 
antioxidant with one lipophilic and one lipophobic part (Kozlov et al., 1999; 
Lykkesfeldt et al., 1998). LPA is synthesized in the mitochondria by lipoic acid 
synthase as part of the de novo synthesis of FA (Hiltunen et al., 2010; 
Morikawa et al., 2001; Wada et al., 1997) and has been shown to be active in 
cellular energy metabolism (reviewed in Bast & Haenen, 2003). 
Huong & Ide (2008) and Yi & Maeda (2006) demonstrated that LPA can 
decrease the PL and TAG concentrations and the cholesterol concentration in 
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serum and liver of rodents. A dose-dependent decrease in both gene expression 
and activity of the enzymes involved in FA synthesis and in the elongation and 
desaturation cascade was observed in that study. LPA has been shown to affect 
the FA composition of fish muscle towards higher levels of EPA (Trattner et 
al., 2007). 
Feeding a combination of sesamin and LPA to rats has been shown to 
decrease the activity and mRNA levels of hepatic lipogenic enzymes in a 
synergistic fashion. The strong effect of sesamin on hepatic FA oxidation 
enzymes is reported to be antagonized by LPA (Ide et al., 2012). The latter 
study showed that even though sesamin and LPA had a very similar effect on 
both mRNA level and activity of lipogenic enzymes, only sesamin had any 
effect on the transcription factor SREBP-1c.  
1.3.3 Genistein 
Genistein is a phytoestrogen formed after hydrolysis of the isoflavone genistin 
found abundantly in soybean. Genistein is known to exhibit antioxidative and 
hormone-like effects (Yuan et al., 2007). Genistein inhibits the oxidation of 
low-density lipoprotein (LDL) in human blood (Safari & Sheikh, 2003) and 
studies on mice have shown that hepatic FA synthase, β-oxidation and CPT1 
activities are significantly lower after genistein supplementation (Ae Park et 
al., 2006). However, genistein has also been shown to act as a potential ligand 
for PPARα, enhancing the expression of genes involved in lipid catabolism 
through activation of CPT1 in human cell lines, a finding which is somewhat 
contradictory (Kim et al., 2004). Other studies have shown that genistein 
treatment has dose-dependent toxic effects on zebrafish embryos (Kim et al., 
2009; Sassi-Messai et al., 2009). 
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2 Lipid metabolism 
Lipid metabolism consists of a mixture of metabolic processes that generate 
energy and primary metabolites from FAs and processes that create 
biologically important molecules (EPA and DHA) from essential FAs (Figure 
1). In turn, dietary FAs act as regulators of gene transcription and consequently 
steer enzyme activity of the same processes (Jump & Clarke, 1999; Hesketh et 
al., 1998).  
 
Figure 2. Inter-relationships between fatty acid homeostasis and gene expression (Modified after 
Hesketh et al., 1998). 
The regulation of lipid homeostasis in salmonids (Figure 2) is a complex 
balance between e.g. lipid uptake, transport, storage, energy utilization and 
biosynthesis. Each single process needs to be controlled independently and also 
in conjunction with other processes (Tocher, 2003). Dietary FAs may alter the 
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amount of functional protein expressed in these processes through a range of 
transcriptional, post-transcriptional and post-translational mechanisms. FAs 
and their metabolites can influence gene expression regulation either indirectly 
by activating different transcription factors in the cytoplasm or directly by 
entering the nucleus by themselves or in association with ligand-activated 
transcription factors. 
2.1 Uptake & transport 
The liver is the crossing point for the exogenous and endogenous transport of 
lipids. The dominant mechanism by which lipids are taken up into cells is 
through binding of lipoproteins to cell surface trans-membrane lipoprotein 
receptors. The expression levels of genes encoding proteins involved in the 
uptake and intracellular transport of FAs in Atlantic salmon are affected by the 
replacement of dietary FO with VO (Torstensen et al., 2009; Stubhaug et al., 
2005a). 
2.1.1 Scavenger receptor class B, type I 
High-density lipoprotein receptor scavenger receptor class B, type 1 (SR-B1) is 
one of the most important cell surface lipoprotein receptors. The expression of 
SR-BI is controlled by a complex matrix of hormones, FAs and other nutrients. 
In turn SR-BI is involved in lipid uptake from the diet and is responsible for 
regulating lipid levels (Malerød et al., 2002).  
Kleveland et al. (2006b) cloned and characterized SR-BI in Atlantic 
salmon. Several transcription factors such as SREBP, Liver X receptor (LXR) 
(reviewed in Rhainds & Brissette, 2004), hepatocyte nuclear factor 4α 
(HNF4α), PPARα and PPARγ (Malerød et al., 2003) have been shown to be 
involved in the regulation of SR-BI expression in humans and rodents. 
2.1.2 CD36 
CD36 is a free FA transporter and a membrane receptor capable of taking up 
modified forms of LDL and FAs. CD36 can also bind HDL. PPARγ is a 
positive regulator of CD36 in rodents. Actually CD36 is a shared target of 
LXR, pregnane X receptor (PXR) and PPARγ (Zhou et al., 2008; Zhou et al., 
2006). Gene expression levels of CD36 are affected by changes in diet 
formulation. Significant downregulation in salmon white muscle has been seen 
after feeding a VO-based diet compared with a FO-based diet. This indicates 
that VO lower FA uptake in fish compared with FO (Torstensen et al., 2009).  
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2.2 Desaturation and elongation of LCPUFA 
The sequential chain of desaturation and elongation steps converting n-6 and n-
3 FA precursors into LCPUFAs has been well described for both rainbow trout 
and Atlantic salmon (Tocher, 2003; Tocher et al., 1989) and is suggested in 
earlier studies to involve the same two enzyme families –  elongases of very 
long fatty acids (ELOVLs) and the fatty acyl desaturases (FAD) (Ruxton et al., 
2005; Cook & McMaster, 2002). Enzyme affinity, especially that of FAD, is 
higher for n-3 FA than for n-6 FA (Tocher & Dick, 1990a; Tocher & Sargent, 
1990; Tocher et al., 1989) and the relative activity in each of the steps in the 
reaction cascade in Figure 3 decreases with increased chain length (Tocher, 
2003). The majority of LCPUFA synthesis takes place in the endoplasmic 
reticulum (ER), with only the last chain-shortening step taking place in the 
peroxisomes (Sprecher, 2000).  
2.2.1 ELOVL and FAD 
Δ6FAD and Δ5FAD are actively expressed in both rainbow trout (Buzzi et al., 
1997; Buzzi et al., 1996; Tocher et al., 1989) and Atlantic salmon (Tocher & 
Dick, 1990b), enabling both species to elongate and desaturate ALA and LA to 
DHA and ARA, respectively. The genes for Δ5FAD (Hastings et al., 2004) and 
Δ6FAD (Zheng et al., 2005a) have been cloned from Atlantic salmon and 
functionally characterized. Four genes have been identified as coding for Δ5 
and Δ6 desaturase in Atlantic salmon (Monroig et al., 2010).  
Buzzi et al. (1997) and (Tocher, 1990) showed that the formation of DHA 
in rainbow trout and Atlantic salmon, respectively, does not primarily involve 
Δ4 desaturation of DPA (22:5n-3), but rather proceeds through a final round of 
elongation and desaturation followed by peroxisomal β-oxidation (the Sprecher 
pathway) (Step I in Figure 3). However, this paradigm has recently been 
revised and it is now clear that another pathway exists for DHA synthesis from 
EPA, involving a Δ4 desaturation of DPA (reviewed in Monroig et al., 2013; 
Li et al., 2010b) (Step II in Figure 3). Morais et al. (2012a) did clone and 
functionally characterize Δ4FAD from Senegalese sole (Solea senegalensis). 
However, Tu et al. (2012) demonstrated that there is an alternative n-3 
LCPUFA elongation pathway, including a Δ8 desaturase that via elongases 
forms 20:3n-3 from ALA and then a Δ6/Δ8 desaturase to form 20:4n-3 in 
barramundi (Lates calcarifer), bypassing the first Δ6FAD desaturation step 
forming  20:3n-3. After desaturation of 20:3n-3, the pathway continues with 
the usual Δ5FAD desaturation (Step III in Figure 3). Monroig et al. (2011) 
showed the ability for ∆8 desaturation (capability to introduce double bonds 
into 20:3n-3 at the ∆8 position) in Atlantic salmon and rainbow trout, among 
other fish species.  
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Figure 3. Elongation and desaturation pathway of n-6 and n-3 fatty acids. (Adapted from 
(Carmona-Antoñanzas et al., 2011; Monroig et al., 2011; Sprecher, 2000; Voss et al., 1991); 
modified after (Trattner, 2009).  
ELOVL5a (Hastings et al., 2004), ELOVL5b and ELOVL2 (Morais et al., 
2009) have been cloned and functionally characterized in Atlantic salmon. 
Atlantic salmon ELOVL5a and ELOVL5b were found to elongate C18 and C20 
PUFA, and ELOVL2 to elongate C20 and C22 PUFA. All three ELOVLs 
showed predominant expression in the intestine and liver, followed by the 
brain. Elongase expression was shown to be under differential nutritional 
regulation, with transcript levels of ELOVL5b and ELOVL2, but not of 
ELOVL5a, significantly increased in liver of salmon fed VO compared with 
salmon fed FO. 
ELOVL4 has been shown to be a critical enzyme in the biosynthesis of both 
saturated and polyunsaturated very long-chain fatty acids having chains 
ranging from C26 to C40. ELOVL4 has been isolated and functionally 
characterized in Atlantic salmon. ELOVL4 has been shown to elongate C20 
and C22 PUFA and to be able to convert EPA and DPA to 24:5n-3, an 
intermediate substrate for DHA biosynthesis (Carmona-Antoñanzas et al., 
2011). In terms of tissue distribution, ELOVL4 mRNA transcripts are most 
abundant in eye, brain and testes. 
24 
The activity of the desaturation/elongation pathway is inhibited in salmonids 
having an adequate supply of n-3 LCPUFA in their natural diet. It has been 
shown that the desaturation and elongation cascade is under feedback 
regulation affected by the concentration of end products (EPA and DHA), as 
well as the availability of substrate FAs (LA and ALA) (Tocher et al., 2003a). 
The desaturation and elongation of ALA have been shown to increase when 
salmonids are fed a diet containing VO rather than FO (Bell et al., 2001; 
Tocher et al., 2001). Several studies have demonstrated that the expression of 
Δ6FAD mRNA is lower in salmon fed FO compared with VO (Leaver et al., 
2008b; Zheng et al., 2005a; Zheng et al., 2005b). Furthermore, when dietary 
FO was replaced with VO, LCPUFA biosynthesis was shown to be regulated 
in a genotype-specific manner. In lean fish compared with fatty fish, ∆5FAD, 
∆6FAD and ELOVL2 were upregulated, which was also reflected in the liver 
FA composition (Morais et al., 2012b). 
2.3 β-oxidation 
The β-oxidation of FAs takes place in both mitochondria and peroxisomes, but 
the mitochondrial β-oxidation is quantitatively more important and can use a 
wide range of different FAs as substrate (Henderson, 1996).  Mitochondria and 
peroxisome β-oxidation pathways have been shown to exhibit broad chain 
length specificity for different FAs (Henderson & Sargent, 1985). β-oxidation 
occurs in peroxisomes for FA chains that are too long to be processed directly 
in the mitochondria, but peroxisomal β-oxidation ceases at octanyl-CoA. Very 
long chain FAs (greater than C22) undergoes initial oxidation in peroxisomes, 
followed by final oxidation in mitochondria. The expression levels of genes 
encoding proteins involved in the β-oxidation of FAs in Atlantic salmon, e.g. 
acyl-CoA oxidase (ACO), CPT1 and CPT-2, have been shown to be negatively 
affected by the replacement of dietary FO with VO (Torstensen et al., 2009). 
2.3.1 Carnitine palmitoyl transferase 1  
For mitochondrial β-oxidation to occur, FAs need to reach the mitochondrial 
inner membrane space. CPT1 is a mitochondrial enzyme positioned in the 
outer mitochondrial membrane that is responsible for the formation of acyl 
carnitines by catalyzing the transfer of the acyl group of a long-chain fatty 
acyl-CoA from coenzyme A. This allows for subsequent movement of the acyl 
carnitine from the cytosol into the inner membrane space of mitochondria.  
25 
2.3.2 Acyl-CoA oxidase  
Peroxisomal β-oxidation requires a specific set of enzymes. Peroxisomal acyl-
CoA oxidase (ACO) is the first and rate-limiting enzyme of peroxisomal β-
oxidation (Kleveland et al., 2006a; Ruyter et al., 1997; Varanasi et al., 1996). 
β-oxidation in the peroxisome starts with the use of ACO for transport of the 
activated acyl group into the peroxisome (Pagot & Belin, 1996).  
 
26 
3 Gene regulation of lipid metabolism 
The regulation of all processes from production through activation and 
deactivation to degradation of proteins involves regulation of gene expression, 
directly or indirectly, at one point or another. The regulation of gene 
expression can occur at any step ranging from DNA-RNA transcription to post-
translational modification of protein. During transcription, the chromatin 
arrangement and changes in DNA structure influence accessibility of promoter 
sequences and activation and activity of transcription factors, and determine 
whether genes are transcribed (Gräff et al., 2011; Schneider & Grosschedl, 
2007). There are three possible outcomes for fully transcribed mRNA in the 
cytoplasm: it may be translated to produce protein, it may be immobilized or 
inactivated and/or it may be degraded.  
3.1 Genome duplication 
The salmonid genome is complex due to an additional genome duplication that 
is believed to have occurred 96 million years ago (Berthelot et al., 2014; Ohno, 
1999; Allendorf & Utter, 1976). Tetraploidizations, or genome duplications, 
are important evolutionary events which were responsible for large increases in 
genome size and diversity early in vertebrate evolution (Ohno et al., 1968).  
In salmonids, around half of all protein coding loci have remained as 
functioning duplicates, but the diploidization process has not come to an end 
(Berthelot et al., 2014; Hordvik, 1998; Young et al., 1998; Allendorf, 1978; 
Bailey et al., 1978). Consequently, a specific locus in one species may still 
have four alleles, while in another species it may be converted to a pair of 
isoloci (e.g. pair of duplicate loci having gene products with identical 
constitution and electrophoretic mobility; (Waples, 1988). Several gene 
duplicates have been cloned and described for salmonids (Morash et al., 2010; 
Evans et al., 2008; Leaver et al., 2007; McKay et al., 2004; Hordvik, 1998; 
Kavsan et al., 1993; Ohno et al., 1968). The existence of such duplicates 
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makes it even more difficult to determine the intriguing gene regulation 
mechanisms in these species. 
In contrast to the continuing diploidization process going on in protein 
coding genes, miRNA genes have almost all been retained as duplicate copies 
(Berthelot et al., 2014). These authors identified 241 miRNA loci in the 
rainbow trout genome, of which 233 (97%) were present in duplicate copies, 
while eight loci only displayed one member of the ohnologous pair (3%). 
3.2 Circadian control 
In mammalian liver, most metabolic pathways, including both lipid and 
cholesterol metabolism (reviewed in Panda et al., 2002), are under circadian 
control, meaning that they display an endogenous, cyclic fluctuation of about 
24 hours (Reppert & Weaver, 2002). Betancor et al. (2014) showed that 
specific genes relating to lipid metabolism and homeostasis are under circadian 
control in the liver of Atlantic salmon. The mechanisms involve interacting 
positive and negative transcriptional feedback loops that drive periodic 
rhythms of the RNA and protein levels. In mammals, the coordination between 
these loops has been shown to be governed by the orphan nuclear receptors, 
e.g. REV-ERB 1α (reviewed in Reppert & Weaver, 2002) and tissue-specific 
post-transcriptional regulation factors, specifically several miRNAs (Du et al., 
2014; Shende et al., 2014; Chen et al., 2013; Shende et al., 2011; Gatfield et 
al., 2009b). REV-ERB 1α has recently been cloned in the liver of Atlantic 
salmon (Betancor et al., 2014), but REV-ERB 1α in fish seems not to 
participate in exactly the same way in the circadian control mechanism as in 
mammals. 
3.3 Transcription factors 
One way for dietary FAs to influence gene expression is by controlling the 
activity or abundance of central transcription factors (Jump et al., 2005). A 
transcription factor is a protein that binds to a specific promoter sequence -30, -
75 and -90 base pairs (bp) upstream of the transcription start site in the 
promoter region, and by doing so controls the transcription of genetic 
information from DNA to mRNA. This function is performed single-handedly 
or in a complex with other proteins that promote (as an activator) or block (as a 
repressor) the binding of RNA polymerase. 
Many transcription factors have been identified as targets for FA regulation, 
including PPARs, SREBPs, hepatic nuclear factors (HNFs), retinoid X receptor 
(RXR) and LXR. Some of these are examined in more detail below.  
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3.3.1 Peroxisome proliferator-activated receptors 
One nuclear receptor family that influences transcription according to 
nutritional state is the PPAR family (Issemann & Green, 1990). PPARs respond 
to changes in lipid and glucose homeostasis (reviewed in Schoonjans et al., 
1996). PPARs are ligand-activated by FAs and eicosanoid metabolites. They 
are not only able to bind to the promoter region of genes involved in the 
metabolism of their ligands, and thereby regulate gene expression, but they 
also serve as intracellular receptors (reviewed in Kersten, 2008). The DNA-
binding domain, which plays an important role in the binding of PPAR to the 
promoter region, has been characterized in Atlantic salmon (Ruyter et al., 
1997). 
There are three subtypes of PPARs in salmonids, PPARα, PPARβ/δ and 
PPARγ, with specific tissue and developmental patterns of expression. The 
PPAR subtypes can be activated by a variety of ligands without showing any 
particularly strict ligand specificity. In rainbow trout, PPARα expression is 
upregulated by SAFA, MUFA, ALA, ARA and DHA and downregulated by 
EPA (Coccia et al., 2014). Similarly, Morash and McClelland (2011) showed 
that a LCPUFA-rich diet upregulated both PPARα and PPARβ. 
As a result of the additional genome duplication event in salmonids, four 
genes coding for four different subtypes of PPARβ/δ have been identified in 
Atlantic salmon (Leaver et al., 2007). Furthermore, two subtypes of PPARγ 
that differ in length, stability and presumably in ligand preferences have been 
described in Atlantic salmon (Andersen et al., 2000; Ruyter et al., 1997).  
PPARα is considered to be the main inducer of β-oxidation (Leaver et al., 
2006). However, PPARα, PPARβ/δ and PPARγ have all been shown to target 
genes coding for the β-oxidation enzymes, CPT1 and ACO, and by doing so 
shift FAs away from esterification and storage, resulting in a decrease in EPA 
and DHA in liver and white muscle of rainbow trout and Atlantic salmon 
(Torstensen et al., 2009; Du et al., 2004; Ruyter et al., 1997). Both PPARα and 
PPARγ have been shown to induce transcription of the transmembrane fatty 
acid transporter CD36 and SR-B1 (Torstensen et al., 2009; Malerød et al., 
2003; Poirier et al., 2001; Motojima et al., 1998). PPARγ is present in two 
forms, PPARγ long, expressed in liver and involved in the regulation of FA 
metabolism, and PPARγ short, suggested to be present in Atlantic salmon 
adipocytes and involved in adipocyte differentiation (Todorčević et al., 2008; 
Vegusdal et al., 2003; Ruyter et al., 1997). 
The expression of PPARβ/δ is reported to be significantly downregulated in 
Atlantic salmon fed VO compared with FO fed fish (Torstensen et al., 2009). 
However, transcription regulators may respond differently to alternative plant-
based feeds depending on genotype. In a study where diet formulation was 
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changed to VO, both PPARα and PPARβ were downregulated in lean fish, but 
this was not observed in fat salmon (Morais et al., 2012b). 
3.3.2 PPARγ coactivator-1 
PPARγ coactivator-1 (PGC-1) has been demonstrated to interact with the 
PPARγ receptor, as well as with other members of the nuclear receptors. PGC-
1 plays a role in the regulation of energy homeostasis, lipid metabolism and fat 
deposition in mammals and lower vertebrates (Lemoine et al., 2010). PGC-1 
greatly increases the transcriptional activity of PPARγ (reviewed in Aranda & 
Pascual, 2001). PGC-1α is also reported to be a potential marker for meat 
quality in pigs (Lefaucheur et al., 2004). PGC-1 has been shown to interact 
with CD36 and CPT-1, resulting in increased FA transport and β-oxidation in 
rodents fed a 30% FO diet (Feillet-Coudray et al., 2013).  
PGC-1α has been cloned and characterized in a cyprinid species 
(Schizothorax prenanti). Here PGC-1α transcription levels in fish muscle seem 
to be positively correlated with intramuscular fat content (Li et al., 2012b). 
3.3.3 Sterol regulatory element-binding proteins 
Another group of key regulators of lipid and cholesterol metabolism are the 
SREBPs, which are attached to the nuclear envelope or bound in ER (reviewed 
by Jump et al., 2005). The FA levels, both intracellular and membrane, are 
under constant supervision by SREBP and are coordinated with de novo lipid 
biosynthesis (Horton et al., 2002). In the nucleus, SREBP binds to the sterol 
regulatory element DNA sequence found in control regions of the target genes. 
This binding leads to the initiation of transcription (Osborne & Espenshade, 
2009). Binding site for SREBPs has been identified in the promoter region of 
salmon Δ6FAD (Zheng et al., 2009) and Minghetti et al. (2011) identified and 
characterized two SREBP genes in salmon that are homologous to mammalian 
SREBP-1 and SREBP-2. The latter study also showed that both Δ5FAD and 
Δ6FAD regulate SREBP-1 and that n-3 LCPUFAs, EPA and DHA 
downregulate SREBP-1 expression in Atlantic salmon.  
Replacement of dietary FO with VO in Atlantic salmon upregulate SREBP-
2 and, as a result, increased expression of genes coding for cholesterol 
biosynthesis (Leaver et al., 2008b; Taggart et al., 2008). As with PPARs, 
SREBPs may respond differently to dietary changes depending on genotype. If 
diet formulation changes to VO, SREBP-1 was upregulated in lean fish, but no 
similar effect could be seen in fat salmon (Morais et al., 2012b). 
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3.3.4 Liver X receptors  
Liver X receptors are transcription factors regulated by sterols and in turn 
regulate key target genes in cholesterol catabolism, storage, absorption and 
transport, as well as de novo FA synthesis. The gene coding for LXR was 
cloned and characterized in salmonids by Cruz-Garcia et al. (2009). 
In a similar fashion to PPAR, ligand binding causes dissociation of the LXR 
from the co-repressors, followed by translocation from the cytoplasm to the 
nucleus where LXR-RXR binds to the LXR response elements in the promoter 
of the target genes, resulting in transcription initiation. In humans post-
transcriptional regulation by miRNAs and post-translational modifications such 
as phosphorylation have been shown to finely tune LXRα target gene 
selectivity (Zhong et al., 2013; Torra et al., 2008). ACO and ELOVL5 are 
possible direct targets of LXR, suggesting that salmon ELOVL5 may be 
regulated in a different way than mammalian ELOVL5, an indirect target of 
LXR, reacting to LXR-dependent increases in SREBP-1. LXR-SREBP-1c 
pathway plays an important regulatory role in hepatic biosynthesis of 
LCPUFAs (Minghetti et al., 2011; Zheng et al., 2004).  
The expression of LXR seems to depend on environmental changes, with 
LXR mRNA levels significantly higher in seawater fish than in freshwater fish 
and young parr tending to have a much higher expression rate than two year-
old adult salmon and that diet changes from FO to VO affect adult fish more 
than pre-smolt fish (Cruz-Garcia et al., 2009).  
Replacing FO with VO in aquafeed causes a decrease in cholesterol content 
and an increase in phytosterols (Pickova & Mørkøre, 2007), which can have 
disruptive effects on cholesterol metabolism in salmonids. Substitution of FO 
with plant products induces genes of cholesterol and FA metabolism (Leaver et 
al., 2008b), which partly may be caused by LXR (Plat et al., 2005), since it is 
unclear whether phytosterols can induce LXR expression in the same way as 
cholesterol. A downregulating effect on LXR expression in rainbow trout fed 
VO has been shown (Cruz-Garcia et al., 2011).  
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4 Post-transcriptional regulation of lipid 
metabolism 
Post-transcriptional regulation is the control of gene expression at the RNA 
level, after transcription and before gene translation. Included within the post-
transcription concept are regulation mechanisms such as modulation of the 
activity of RNA binding proteins, alternative splicing, RNA degradation, 
addition of poly(A) tail, processing, RNA editing and exportation from the 
nucleus to the cytoplasm, removal of the 5-prime cap from mRNA and finally 
regulation of the actual translation. All of these are involved in modifying the 
stability and distribution of the mRNA, ultimately affecting the outcome of the 
gene expression machinery. 
During the last decades the picture of gene regulation has become even 
more complex with the discovery of epigenetic regulation. The four major 
components of epigenetic regulation are promoter methylation, histone 
modification, chromatin conformation changes and altered expression by non-
coding RNAs, especially miRNAs (Moore, 2005; Bartel, 2004; Ambros, 2001).  
The focus in this thesis is on miRNAs as a candidate for gene translation 
regulation.  
4.1 MicroRNAs and gene silencing 
MiRNAs are a family of short (approximately 21-25 nucleotides long) 
endogenous non-coding RNAs involved in a vast number of evolutionary 
conserved regulatory pathways (Bartel, 2009; Bartel, 2004; Lau et al., 2001). 
MiRNAs function as guide molecules in the post-transcriptional gene silencing 
process by base pairing with target mRNAs, which in turn leads to cleavage of 
mRNA or translational repression.  
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4.1.1 Background 
The first miRNA was identified in 1993, when the gene lin-4, which controls 
the developmental timing in Caenorhabditis elegans, was shown not to code 
for proteins, but instead acted as 22nt RNA transcripts. This transcript 
regulated its target, lin-14, by base-pairing to the mRNA 3’-UTR with 
imperfect sequence complementarity (Lee et al., 1993; Wightman et al., 1993). 
This phenomenon was first thought to be unique for C. elegans, but the 
situation was reconsidered when a second miRNA, let-7, identified by Reinhart 
et al. (2000), was found to be conserved in several other species (Griffiths-
Jones et al., 2006), together with its target lin-41 (Pasquinelli et al., 2000). 
Today, genes regulated by miRNAs and the miRNAs themselves have been 
identified in a wide range of vertebrates and plants and are believed to be 
present in all multicellular eukaryotes (Bartel, 2009) and responsible for more 
than 60% of the regulation of protein coding genes (Dweep et al., 2011).  
4.1.2 MicroRNA biogenesis 
MicroRNAs are transcribed individually, in clusters or in conjunction with the 
protein that they regulate. They are located as individual (monocistronic) or 
(polycistronic) clusters and can be generated from either the sense or the 
antisense strand of the gene that codes them (Figure 4) (Lau et al. 2001).  
 
Figure 4. Examples of different secondary structures of miRNAs (red) and their flanking regions 
(black) (adapted after Lau et al., 2001): A) miRNA residing on the 5′ arm of the fold-back 
structure, B) miRNA residing on the 3′ arm of the fold-back structure, C) two miRNAs cloned 
from both strands of the fold-back structure. A-C are examples of monocistronic located miRNAs 
and D) is a polycistronic miRNA cluster. 
The synthesis of miRNA (Figure 5) occurs in two different cell compartments; 
the nucleus and the cytoplasm. MiRNAs are transcribed within the nucleus to 
form large precursors several kilobases long, called primary miRNAs (pri-
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miRNAs) typically containing one to several characteristic stem loop structures 
(Kim, 2005).  
 
Figure 5. Biosynthesis of miRNA. The miRNAs are transcribed as primary transcripts (pri-
miRNAs) by RNA polymerase II. Each pri-miRNA contains one or more hairpin structures that 
are recognised and processed by Drosha and DGCR8, generating a 70-nucleotide stem loop 
known as the precursor miRNA (pre-miRNA), which is actively exported to the cytoplasm by 
exportin-5. In the cytoplasm, the pre-miRNA is recognized by Dicer and TRBP. Dicer cleaves the 
precursor, generating a 20-nucleotide mature miRNA duplex. In general, only one strand is 
selected as the biologically active mature miRNA and the other strand is degraded. The mature 
miRNA is loaded into the RNA-induced silencing complex (RISC), which contains argonaute 
(Ago) proteins and the single-stranded miRNA. Mature miRNA allows the RISC to recognize 
target mRNAs through partial sequence complementarity with its target. The RISC can inhibit the 
expression of the target mRNA through two main mechanisms that have several variations: 
removal of the polyA tail (deadenylation), followed by mRNA degradation; and blockade of 
translation at the initiation step or at the elongation step or causing ribosome stalling. RISC-
bound mRNA can be localized to sub-cytoplasmatic P-bodies, where they are reversibly stored or 
degraded (Modified after Inui et al., 2010). 
The processing of the pri-miRNA starts with the binding of DGCR8 to the pri-
miRNA flanking sequences, followed by the positioning of the RNase III type 
endonuclease Drosha and the subsequent stem loop cleavage approximately 
one helical turn, or 11 bp, from the junction between the flanking sequences 
and the stem loop. This process generates a characteristic hairpin RNA 
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precursor called pre-miRNA (Lee et al., 2003). The pre-miRNAs are roughly 
65-70 nt long hairpins and are exported through the nucleus membrane into the 
cytoplasm by Exportin-5.  
After entering into the cytoplasm, the pre-miRNAs are recognized and 
cleaved by Dicer, another RNase III enzyme removing the hairpin loop. The 
miRNAs are now RNA duplexes 22 nt in length.  
Only one strand of the duplex strands (the miR strand) is loaded onto an 
argonaute protein (Ago). The other strand is degraded. Which of the two 
strands that is loaded onto Ago is somewhat unclear, but in general it is the 
strand with a less stable 5’end (fewer bindings) that enters into Ago. The RNA 
induced silencing complex (RISC) is formed and is now capable of binding to, 
and thereby repressing, target mRNA expression (Treiber et al., 2012). The 
miRNA binds to the target mRNA 3′UTR region with imperfect 
complementarity except for a region in the miRNA (from 2nd to 7th nt) that 
creates an almost perfect match with the so-called seed region in the mRNA. 
The miRNAs are grouped into families based in similarities in seed region 
(Bartel, 2009). This short seed region is used in computational prediction of 
miRNA targets (Betel et al., 2010; Xiao et al., 2009; Shahi et al., 2006; Krek et 
al., 2005; Lewis et al., 2005; Rehmsmeier et al., 2004). 
With the rise in next generation sequencing (NGS) platforms generating 
millions of reads, a new magnitude of variability in mature miRNA sequences 
has been observed. These sequence variants are referred to as isomiR. These 
are multiple mature sequences that have variations with respect to the reference 
miRNA sequence annotated in miRBase. In many cases, the miRNA* 
sequence and its isomiRs are also observed (Morin et al., 2008).  
4.1.3 Role of miRNA 
The miRNAs have a profound impact on the development of all vertebrates. 
Knock-out animals lacking the Dicer enzyme responsible for processing the 
pre-miR into its mature form cannot live (Kloosterman & Plasterk, 2006; 
Ambros, 2004; Wienholds et al., 2003). In mammals, miRNAs have been 
shown to be capable of regulating every aspect of cellular activity, including 
development and proliferation, differentiation, metabolism, viral infection, 
epigenetic modulation, apoptotic cell death and tumor genesis (Lin et al., 2012; 
Bushati & Cohen, 2007; Esau & Monia, 2007; Bartel, 2004; Carrington & 
Ambros, 2003). One single miRNA can regulate more than 200 mRNAs and 
one single mRNA may be regulated by several different miRNAs (Dweep et 
al., 2011). However, very few miRNA targets have actually been identified by 
biological methods.  
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Specific miRNAs have received attention due to their role as key metabolic 
regulators in mammals (Sacco & Adeli, 2012; Dávalos et al., 2011; Fernández-
Hernando et al., 2011; Aoi et al., 2010; Safdar et al., 2009; Krützfeldt & 
Stoffel, 2006).  
In fish, changes in miRNA have been documented during ontogeny 
(Mennigen et al., 2013; Bizuayehu et al., 2012), in egg (Ma et al., 2012), larval 
and juvenile growth (Campos et al., 2014) and in response to food ingestion 
(Mennigen et al., 2012). 
Even though miRNAs exhibit a high level of sequence conservation, the 
timing and location of miRNA expression is not strictly conserved. Variation 
in miRNA expression is more pronounced the greater the differences in 
physiology, and it is likely that changes in miRNA expression play a role in 
shaping the physiological differences produced during development (Ason et 
al., 2006). One indication of this can be seen in rainbow trout, where Mennigen 
and his team studied selected liver-specific miRNAs (Mennigen et al., 2014a; 
Mennigen et al., 2014b; Mennigen et al., 2013; Mennigen et al., 2012). They 
expected both miR-33 and miR-122 to be linked to the regulation of cholesterol 
and lipid metabolism as well as glycose homeostasis in the same way as in 
mammals. However, they found that the metabolic consequences of miRNA-
122 inhibition differ between vertebrate species and that genes involved in 
hepatic lipid lipogenesis and β-oxidation are positively affected in rainbow 
trout but not in mammals, where inhibition of miR-122 results in decreased 
expression of lipogenic genes. 
Naturally occurring variation in miRNAs 
Naturally occurring variation in miRNA genes or miRNA target sites may also 
contribute to normal phenotypic variations. Some of these phenotypic 
differences may affect economically important traits, such as that affecting 
muscle meatiness in Texel sheep (Clop et al., 2011; Clop et al., 2006). A single 
nucleotide polymorphisms (SNPs) located in the putative 3’UTR target sites of 
miR-224 and the miR-30 family have been shown to affect the transcription 
rate of genes and transcription factors involved in pig lipid metabolism, which 
can have an effect on lipid composition and pork quality (Bartz et al., 2014; 
Stachowiak et al., 2014). Peñaloza et al. (2013) suggested that SNPs in the 
flanking region of the myostatin gene of Atlantic salmon affecting the 
regulation of muscle development and growth might act through interfering 
with the highly conserved miRNA target site. The same phenomenon was later 
demonstrated by McFarlane et al. (2014) in mice. If this is also the case for 
lipid composition in Atlantic salmon, it might prove to be suitable for selective 
breeding and of commercial importance. 
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4.1.4 MicroRNAs in salmonids 
The number of known fish miRNAs is not comparable to those for human and 
mouse, considering the conserved nature of miRNAs among different species. 
Today the miRBase database contains 1881 precursors and 2588 mature human 
miRNAs, compared with much lower number of entries from Atlantic salmon 
(371 precursors and 498 mature miRNAs) and no entries for rainbow trout. 
However, not all the Atlantic salmon and rainbow trout miRNAs identified to 
date have been uploaded onto the miRBase registry (Bekaert et al., 2013; 
Salem et al., 2010; Ramachandra et al., 2008). 
To the best of my knowledge, Andreassen et al. (2009) were the first to 
indicate that the Atlantic salmon genome contains conserved 7-mers in the 
3’UTRs identical to miRNA target sequences, suggesting that miRNA and 
RNA silencing also play a role in controlling protein expression in S. salar. 
Using computer predictions, Andreassen et al. (2009) were able to identify four 
target motifs to complementary conserved miRNA families (ssa-miR-101, ssa-
miR-199, ssa-miR-144, ssa-miR-543, ssa-miR-446b-3-3p, ssa-miR-425-5, ssa-
miR-731 and ssa-miR-489). Correspondingly, Ramachandra et al. (2008) were 
the first to clone and characterize rainbow trout miRNA. They identified 14 
conserved miRNAs that were involved in regulation of maternal mRNA 
degradation during early embryogenesis. These 14 conserved miRNAs were 
included in the 54 miRNAs cloned and identified in a pooled sample consisting 
of nine somatic tissues from immature (~1-year-old) rainbow trout (Salem et 
al., 2010). The first more complete transcriptome analysis of 496 miRNAs in 
unfertilized eggs of rainbow trout was performed by Ma et al. (2012). 
Barozai (2012) and (Reyes et al., 2012) identified 102 and 307 mature 
miRNAs, respectively, belonging to 46 different miRNA families in Atlantic 
salmon from expressed sequence tag (EST) sequences based on bioinformatics 
approaches. These miRNAs were later identified by Bekaert et al. (2013) and 
Andreassen et al. (2013) using deep sequencing. All Atlantic salmon entries in 
miRBase version 21 so far have been made by Andreassen et al. (2013), but 
Bekaert et al. (2013) identified a total of 547 miRNA genes. However, all NGS 
studies on salmonids to date have mainly been conducted on egg or juvenile 
fish pre-smoltification (Andreassen et al., 2013; Bekaert et al., 2013; Ma et al., 
2012). 
Identification and characterization of miRNAs expressed in the liver of 
mature Atlantic salmon and discovery of novel liver-predominant miRNAs 
would be an important step towards understanding the molecular mechanisms 
regulating hepatic LCPUFA synthesis. 
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5 Objectives 
As Atlantic salmon is among the most popular fish species in the Western diet, 
the content of EPA and DHA in Atlantic salmon fillet and factors influencing 
these amounts are important. This thesis focuses on molecular regulation of 
lipid metabolism in Atlantic salmon with the main emphasis on n-3 LCPUFA 
biosynthesis. Understanding the molecular mechanisms behind transcriptional 
regulation of LCPUFA biosynthesis will enable optimization of the activity of 
the n-3 LCPUFA pathway to enable efficient and effective use of e.g. VO in 
aquaculture.  
 
Specific objectives of the studies described in Papers I-V were to: 
 
 Study the effect of minor compounds, often polar, from linseed oil in 
combination with sesamin on lipid metabolism in rainbow trout (Paper 
I) 
 Study the effect of sesamin supplementation to vegetable oil-based diets 
on the expression of genes related to FA metabolism and on the FA 
composition in Atlantic salmon after in vivo trials (Paper II) 
 Evaluate the effects of different bioactive compounds in vitro – a 
mixture of sesamin/episesamin, sesamin, lipoic acid and genistein, all of 
which are known to act as either antioxidants and/or influence lipid 
homeostasis in mammals (Paper III) 
 Identify and evaluate potential endogenous control miRNA genes and 
compare expression of these and of other selected miRNAs in different 
tissues. The purpose was to create knowledge for coming larger studies, 
including treatments. The identification of specific miRNAs and 
evaluation of quantitative real-time polymerase chain reaction (qPCR) 
analysis of Atlantic salmon miRNAs may be of economic interest in 
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terms of e.g. feeding regimes and treatments of diseases in aquaculture 
of Atlantic salmon (Paper IV) 
 To identify and sequence all major expressed miRNAs in the liver of 
Atlantic salmon post-smoltification using deep sequencing, in order to 
find out more about the expression and regulation of lipid related genes 
in the liver of Atlantic salmon. Such knowledge is important to 
understanding the mechanisms through which salmonids control and 
regulate the high lipid levels on which they are dependent for optimal 
growth (Paper V). 
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6 Material and methods  
This chapter provides a short description of the material and methods used in 
the studies included in this thesis. For more details of the specific procedures, 
see Papers I-V.  
6.1 Design of the experimental series 
An overview of the materials tested, specific methods, software and techniques 
used in the three feeding trials and in the two microRNA studies are given in 
Tables 1 and 2, respectively.  
In Paper I, rainbow trout with an average final weight of 73 g were fed 
vegetable oil mixtures with different combination linseed oil - commercial 
linseed oil (LO), purified linseed oil triacylglycerols (TAG) with the polar 
fraction removed and mixed linseed-sunflower oil (6:4 v/v) (MO). The effects 
of sesamin supplementation, content of α- and γ-tocopherols and FA 
composition were then evaluated, as well as gene expression of lipid related 
genes in liver and white muscle. 
In Paper II, Atlantic salmon with an average final weight of 554 g were fed 
vegetable oil-based diets with different inclusions of sesamin. The diets used 
differed in n-6/n-3 fatty acid (FA) ratio (0.5 and 1) and sesamin content (high 
5.8 g/kg, low 1.16 g/kg and no sesamin). The oils used in the feeds were a 
mixture of rapeseed, linseed and palm oil. The fish were fed for 4 months. The 
effects of sesamin supplementation on FA composition and expression of 
hepatic genes involved in transcription, lipid uptake, desaturation, elongation 
and β-oxidation in liver and white muscle were evaluated (Table 1). 
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Table 1. Summary of experimental design and content for Papers I -III 
 Paper I Paper II Paper III 
Species Rainbow trout Atlantic salmon Atlantic salmon 
Fish final weight 73 g 554 g 1300 g 
Samples a) Liver/white muscle Liver/white muscle Hepatocytes  
Sample size b) 1.7 mg 1.7 mg 1.7 mg 
Number of replicates  6cd) 6cd) 6d) 
Environmental 
conditions 
Non-chlorinated tap 
water 14.5 °C 
Seawater at 12 °C Seawater at 10 °C 
Control dietd) Commercial fish feed Commercial fish feed Commercial fish feed 
Treatment Sesamin Sesamin/episesamin 
Sh = 5.8 g/kg feed  
Sl = 1.16 g/kg feed 
Lipoic acid 
Sesamin/episesamin  
Genistein 
Vegetable oil diete) Linseed oil (LO) 
Linseed oil 
Triacylglycerols 
(TAG) 
Mixed linseed-
sunflower oil (6:4 v/v) 
(MO) 
V0.5 = 0.5 n-6/n-3 FA 
V1 = 1.0 n-6/n-3 FA 
 
Measurements Lipid analysis Lipid analysis Lipid analysis 
 Gene expression Gene expression Gene expression 
 Content of α- and γ-
tocopherols 
  
Target genes PPARα, PPARβ1A, 
PPARγ, CPT1, 
∆6FAD, ACO 
PPARα, PPARβ1A, 
PPARγ, PGC-1, 
SREBP-1, SREBP-2, 
LXR, CD36, SP-B1, 
ELOVL2, ELOVL5a, 
ELOVL5b, ∆5FAD, 
∆6FAD, ELOVL4, 
ACO 
PPARα, PPARβ1A, 
PPARγ, CD36, 
ELOVL2, ELOVL5a, 
∆5FAD, ∆6FAD, ACO 
Housekeeping gene NUOR NUOR RPL2 
a) Only liver was tested in gene expression experiments.  
b) For the gene expression studies only 
c) All tests performed in triplicate 
d) All diets contained the recommended levels of vitamins and minerals 
e) Rapeseed, linseed and palm oil 
In Paper III, hepatocytes were isolated from Atlantic salmon (1300 g) 
according to the two-step collagenase procedure (Kjær et al., 2008; Dannevig 
& Berg, 1985; Seglen, 1976). The fish were kept in seawater at 10oC and fed a 
commercial diet prior to isolation of hepatocytes. Lipoic acid, genistein, 
episesamin and sesamin were added individually to the culture media of the 
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Atlantic salmon hepatocytes. An array of gene expression assays was designed 
covering transcription factors and genes coding for proteins/enzymes involved 
in lipid metabolism (for genes analyzed, see Table 1). The FA composition in 
Atlantic salmon hepatocytes was also analyzed. 
Table 2. Summary of experimental design and content for Papers IV & V 
 Paper IV Paper V 
Species Atlantic salmon pre-
smoltification 
Atlantic salmon post-
smoltification 
Fish size 10 g (10 months old) 1 300 g 
Samples  Liver, white muscle, red 
muscle, heart, brain, stomach, 
gills, intestine and kidneya) 
 
Liver b) 
Sample size c) 0.04 g tissue/individual ~1 g 0.17 g liver/individual~1 g 
Number of replicates  3 d) 6 
Environmental conditions Freshwater ‘Dalälven’ at 10 
°C 
Seawater at 12 °C 
Diete) Commercial fish feed Commercial fish feed 
Treatment Pilot study Pilot study 
Measurements Next generation sequencing 
miRNA expression using 
qPCR 
Next generation sequencing 
Target genes ssa‐let‐7a, ssa‐miR‐16a, ssa‐
miR‐16b, ssa‐miR‐194a, ssa‐
miR‐22a, ssa‐miR-22b, ssa‐
miR‐27c, ssa‐miR-26b, ssa‐
miR‐92a‐1, ssa‐miR‐122, 
ssa‐miR‐722, ssa‐miR‐21‐1, 
ssa‐miR‐143‐1 
 
Endogenous control ssa-miR-27c  
a) 1 g of somatic tissue were collected and mixed.  
b) 1 g of liver tissue from each individual were collected and mixed.  
c) 1 g of the total pool was used for NGS. 
d) All tests performed in triplicate 
e) All diets contained the recommended levels of vitamins and minerals 
In Paper IV, the tissue samples used for miRNA analysis were collected from 
Atlantic salmon of approximately 10 g and 10 months of age and from the liver 
of six mature Atlantic salmon post-smoltification (Table 2). Since this was the 
first study to identify miRNA in Atlantic salmon, it was conducted as a pilot 
study, with one commercial diet fed to the fish.  
The miRNA isolation and enrichment and complementary DNA (cDNA) 
libraries for two pooled samples from three individuals, each containing liver, 
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heart, brain, kidney, spleen, intestine, gill, white and red muscle and mature 
liver, and Illumina sequencing were constructed and executed by Vertis 
Biotechnology AG (Germany; http://www.vertisbiotech.com/).  
Deep sequencing miRNA analysis was performed by our research group 
(unpublished results). Based on these unpublished data, miRNA candidates 
potentially suitable as endogenous controls in future expression studies were 
identified. In addition, the expression of certain miRNAs known to be related 
to lipid metabolism (Table 2) in different tissues of Atlantic salmon was 
investigated using a modified traditional TaqMan® assay specially designed for 
miRNAs in qPCR expression analysis.  
In Paper V, all major miRNAs expressed in liver of Atlantic salmon at the 
post-smoltification stage were identified and sequenced using deep sequencing 
analysis of NGS data generated by the Illumina® HiSeq™ 2000 Sequencing 
System.  
6.2 Lipid analysis 
Total lipids from diets, tissue, cells and the medium were extracted using 
hexane:isopropanol (3:2 by vol.) (Hara & Radin, 1978).  
Total lipids of muscle tissue and liver were separated into TAG and PL on 
thin-layer chromatography according to Pickova et al. (1997). Total lipids in 
the diets and the TAG and PL were methylated to fatty acid methyl esters 
(FAME) following the method described by Appelqvist (1968) and analyzed 
with gas chromatography according to Trattner et al. (2008a) (Table 3). The 
peaks were identified by comparing their retention times with a standard 
mixture.  
6.3 Sesamin/episesamin analysis and tocopherol 
determinations  
For the analysis of sesamin, episesamin, α- and γ-tocopherols in oils, feed and 
fish white muscle, lipids were dissolved in hexane and analyzed by high 
performance liquid chromatography (HPLC) using a similar system, column 
and conditions as described by Moazzami and Kamal-Eldin (2006). The 
concentrations of α- and γ-tocopherols and sesamin were determined by 
reference to authentic standards using the linear equation obtained from 
triplicate five-point standard curves. 
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6.4 Gene expression analysis 
Gene expression in liver (Papers I and II) and in white muscle (Paper I only) 
was investigated by qPCR using an array of target genes coding for enzymes 
involved in lipid homeostasis.  
Table 4a. Sequences of primers used to amplify housekeeping genes and corresponding GenBank 
accession numbers used in primer design 
Primer Primer pair 
(5’-3’) 
Sequence GenBank 
Acc. no 
NUORa 
Forward CAACATAGGGATTGGAGAGCTGTACG 
DW532752 
Reverse TTCAGAGCCTCATCTTGCCTGCT 
EF1-αb 
Forward CACCACCGGCCATCTGATCTACAA 
AF321836 
Reverse TCAGCAGCCTCCTTCTCGAACTTC 
RPL2c 
Forward TAACGCCTGCCTCTTCACGTTGA 
CA049789 
Reverse ATGAGGGACCTTGTAGCCAGCAA 
ETiFc 
Forward CAGGATGTTGTTGCTGGATGGG 
DW542195 
Reverse ACCCAACTGGGCAGGTCAAGA 
Abbreviations: RPL2 = RNA polymerase II polypeptide, EF1-α = elongation factor 1α, NUOR = NADH-ubiquinone oxidoreductase, ETiF = 
eukaryotic translation initiation factor 3. Already designed and validated in a) Bahuaud et al. (2010), b) Jorgensen et al. (2006), c) Castro et al. (2011).  
Total RNA was isolated from fish liver and white muscle (Paper I only) using 
the spin purification method followed by DNase treatment. Total RNA was 
quantified and reverse transcription first strand cDNA was synthesized using 
the High-Capacity cDNA Archive kit. Real-time PCR analysis of the relative 
abundance of mRNA was assessed using Power or Fast SYBR® Green 
chemistry and gene-specific primers designed using available Atlantic salmon 
sequences from the online version of GenBank®(NCBI) (Trattner et al., 
2008c), using the Primer Express® software or copied from literature 
references.  
Primers for qPCR analysis with corresponding GenBank accession numbers 
are listed in Table 4a-c. The same primers were evaluated and used for both 
Atlantic salmon and rainbow trout except for the PPARγ(long/short) reverse 
primer, which was redesigned for the rainbow trout study. 
All samples were run simultaneously for each gene in triplicate, with a non-
template control on each plate. A melt curve analysis was performed after each 
run to ensure that only a single product was amplified.  
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Table 4b. Sequences of primers used to amplify transcription factors and corresponding GenBank 
accession numbers used in primer design 
Primer Primer pair 
(5’-3’) 
Sequence GenBank Acc. 
no 
PPARαa 
Forward TCCTGGTGGCCTACGGATC 
DQ294237 
Reverse CGTTGAATTTCATGGCGAACT 
PPARβ1Ab 
Forward GAGACGGTCAGGGAGCTCAC 
AJ416953 
Reverse CCAGCAACCCGTCCTTGTT 
PPARγ 
(long)e 
Forward CATTGTCAGCCTGTCCAGAC 
AJ292963 
Reverse TTGCAGCCCTCACAGACATG 
PPARγ 
(long/short) 
Forward CATTGTCAGCCTGTCCAGAC 
AJ292963 
Reverse ATGTGACATTCCCACAAGCA 
PGC-1α 
Forward CAACCACCTTGCCACTTCCT 
FJ710605.1 
Reverse CGGTGATCCCTTGTGGTCAT 
LXRc 
Forward GCCGCCGCTATCTGAAATCTG 
FJ470290 
Reverse CAATCCGGCAACCAATCTGTAGG 
SREBP-1 
Forward GACAAGGTGGTCCAGTTGCT 
NM001195818 
Reverse CACACGTTAGTCCGCATCAC 
SREBP-2d 
Forward TCGCGGCCTCCTGATGATT 
NM001195819 
Reverse AGGGCTAGGTGACTGTTCTGG 
Abbreviations: PPAR = peroxisome proliferator-activated receptor, PGC-1α = proliferator-activated receptor gamma coactivator 1 alpha, LXR = liver 
X receptor α, SREBP = sterol regulatory element binding protein. Already designed and validated in a) Jorgensen et al. (2006), b) Kleveland et al. 
(2006a), c) Cruz-Garcia et al. (2009), d) Minghetti et al. (2011). e) Used for rainbow trout in Paper I only. 
Elongation factor 1a (EF1α), NADH-ubiquinone oxidoreductase (NUOR), 
eukaryotic translation initiation factor 3 (ETiF) and RNA polymerase II 
polypeptide (RPL2) were evaluated for their stability across all experimental 
variables and samples. The most stable reference gene was then chosen using 
the DataAssist software version 2.0. ΔCT was calculated by subtracting the CT 
for the reference gene from the CT for the gene of interest. The relative 
expression was then calculated by comparing the ΔCT values for fish fed the 
different experimental diets with fish fed the standard fish oil diet using the 
term 2-ΔΔCT and reported as arbitrary fold change units (Livak & Schmittgen, 
2001). 
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Table 4c. Sequences of primers used to amplify genes involved in uptake, β-oxidation, 
desaturation and elongation of FA and the corresponding GenBank accession numbers used in 
primer design 
Primer Primer pair 
(5’-3’) 
Sequence GenBank 
Acc. no 
CD36a 
Forward GGATGAACTCCCTGCATGTGA 
AY606034 
Reverse TGAGGCCAAAGTACTCGTCGA 
SR-B1b 
Forward AACTCAGTGAAGAGGCCAAACTTG 
DQ266043 
Reverse TGCGGCGGTGATGATG 
ACOb 
Forward CCTTCATTGTACCTCTCCGCA 
DQ364432 
Reverse CATTTCAACCTCATCAAAGCCAA 
CPT1a 
Forward GTACCAGCCCCGATGCCTTCAT 
AM230810 
Reverse TCTCTGTGCGACCCTCTCGGAA 
Δ5FADa 
Forward GAGAGCTGGCACCGACAGAG 
AF478472 
Reverse GAGCTGCATTTTTCCCATGG 
Δ6FADa 
Forward AGAGCGTAGCTGACACAGCG 
AY458652 
Reverse TCCTCGGTTCTCTCTGCTCC 
ELOVL2c 
Forward CGGGTACAAAATGTGCTGGT 
TC91192 
Reverse TCTGTTTGCCGATAGCCATT 
ELOVL4d 
Forward TTGTCAAATTGGTCCTGTGC 
HM208347 
Reverse TTAAAAGCCCTTTGGGATGA 
ELOVL5ac 
Forward ACAAGACAGGAATCTCTTTCAGATTAA 
AY170327 
Reverse TCTGGGGTTACTGTGCTATAGTGTAC 
ELOVL5bc 
Forward ACAAAAAGCCATGTTTATCTGAAAGA 
DW546112 
Reverse CACAGCCCCAGAGACCCACTT 
Abbreviations: CD 36 = cluster of differentiation 36, SR-B1 = scavenger receptor class BI, ACO = acyl-CoA oxidase, CPT1 = carnitine palmitoyl 
transferase I, Δ5FAD = Δ5 desaturase, Δ6FAD = Δ6 desaturase, ELOVL = elongation of very long chain fatty acids gene. Already designed and 
validated in: a) Trattner et al. (2008c), b) Kleveland et al. (2006a), c) Morais et al. (2009), d) Carmona-Antoñanzas et al. (2011).   
The RT-PCR assay for PGC-1α was designed using the cDNA sequence from 
rainbow trout. 
6.5 MicroRNA analysis 
Juvenile Atlantic salmon (53 g) approximately 10 months old were reared 
under standard conditions at the Älvkarleby research station. Five fish were 
sacrificed pre-smoltification and tissues were dissected and stored in 
RNALater until further miRNA isolation. From each fish, the liver, spleen, 
kidney, brain, heart, intestine, stomach, gill, red and white muscle were 
collected. A pool (Pool 1) of the different somatic tissues was constructed from 
three fish, with roughly 0.03 g taken from each tissue. A corresponding pool 
(Pool 2) of six liver samples from fish post-smoltification (1300 g) was 
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constructed for further miRNA extraction and cDNA library synthesis. The 
tissues in the two pools were ground under liquid nitrogen. 
All miRNA isolation and enrichment and construction of cDNA libraries 
for Illumina sequencing were performed by Vertis Biotechnology AG, 
Germany (http://www.vertisbiotech.com/). 
The RNA samples were separated on denaturing 15% polyacrylamide gel. 
As molecular mass standard, a mixture of oligonucleotides with size 19 nt and 
29 nt was loaded. This mixture was also used as internal size marker in the 
RNA samples (Figure 6A). The small RNA fractions with a length of 19-29 
bases were obtained by passive elution of the RNAs from the gels. The eluted 
miRNA was then precipitated with ethanol and dissolved in water. 
 
 
Figure 6. A) Separation of small RNA samples on denaturing 15% polyacrylamide gels for 
extraction of miRNA in the size range 19-29 nt and B) Analysis of PCR-amplified cDNAs on a 
Shimadzu MultiNA microchip electrophoresis system. M = 25 bp ladder. 
6.6 Next Generation Sequencing 
Illumina Sequencing-by-Synthesis enables discovery and profiling of 
microRNAs without prior genome annotation. The cDNA samples were pooled 
in equimolar amounts and the cDNA pool was sequenced on an Illumina® 
HiSeq™ 2000 Sequencing System (Illumina Inc., San Diego, CA) following 
the manufacturer’s instructions at Vertis Biotechnology AG (Freising-
Weihenstephan, Germany). 
6.7 Computational methods 
The dataset of small RNA were annotated to identify known miRNAs. Any 
miRNAs with conserved sequences matching previously discovered S. salar 
miRNAs were identified by a Basic Local Alignment Search Tool (BLAST) 
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search against MiRBase database version 21 (http://microrna.sanger.ac.uk/) 
using the CLCbio CLC Genomics Workbench for comparing the datasets 
against currently released miRNAs in miRBase v.21 using the default settings. 
Only data from the mature liver (Pool 2) were analyzed in this thesis. 
After being classified into different categories based on sequence similarity, 
the remaining reads of the datasets were compared against currently released 
miRNAs of Danio rerio, Cyprinus carpio, Hippoglossus hippoglossus, 
Takifugu rubripes, Ictalurus punctatus, Oryzias latipes, Paralichthys olivaceus 
and Tetraodon nigroviridis in miRBase. Additional miRNAs identified were 
considered to be homologues to the published miRNAs if they had less than 
two mismatches, and were named accordingly.  
Finally, all the annotated miRNAs were compared against the Atlantic 
salmon miRNAs identified by Barozai (2012), Bekaert et al. (2013) and 
Andreassen et al. (2013) and against miRNAs cloned and sequenced for 
rainbow trout (O. mykiss) (Ma et al., 2012; Salem et al., 2010; Ramachandra et 
al., 2008) to identify conserved miRNAs (Griffiths-Jones et al., 2008). 
6.8 MicroRNA expression analysis 
6.8.1 Candidates for endogenous controls 
The expression of seven putative endogenous control genes (ssa-let-7a, ssa-
miR-16a, ssa-miR-16b, ssa-miR-194a, ssa-miR-22a, ssa-miR-22b and ssa-miR-
27c) was examined with regard to their tissue distribution and use as 
endogenous controls in microRNA expression studies. 
By modification of the traditional TaqMan® assay concept by introduction 
of a target-specific stem-loop reverse transcription (RT) primer, it was possible 
to overcome the problem with the short length of mature miRNA without 
risking target specificity and precision in quantification. The primers used are 
presented in Table 5.  
The stability and suitability of the miRNAs across all experimental 
variables and samples was tested using the DataAssist software version 2.0 
(Applied Biosystems of Life Technologies, Foster City), where a low score 
indicates a stable control. The tissue distribution of miRNAs was tested using 
white muscle as reference tissue and ssa-miR-27c as the endogenous control 
gene. 
6.8.2 Tissue distribution of selected miRNA 
Expression of miRNA in gills, heart, brain, liver, stomach, spleen, kidney, red 
muscle, intestine and white muscle was investigated by qPCR using a selection 
of miRNA genes known to be involved in lipid homeostasis in mammals. The 
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miRNAs selected were ssa-miR-26b, ssa-miR‐92a‐1, ssa-miR‐122 and ssa-
miR‐722, which showed a high presence in liver, and miR‐21‐1, which was 
common in muscle (unpublished NGS data on juvenile Atlantic salmon pre-
smoltification). In previous studies, ssa-miR‐143 has been connected to lipid 
metabolism in human and porcine adipose tissues (Wang et al., 2011; Esau et 
al., 2004) and was included in this study. In addition to its presence in liver, 
ssa-miR‐122 was chosen since documented connections to the metabolism of 
lipids have been reported (Esau et al., 2006b). 
6.9 Statistical analysis 
All data in tables are presented as mean value ± standard deviation (SD). 
Differences between values were considered significant at P≤0.05. FAs were 
compared using the General Linear Model in SAS statistical software. The 
model included the fixed effect of treatment and random effect of individual. 
Correlation tests were performed using Minitab 15 statistical software. Relative 
expression of the different genes was determined and mean values and SD 
were calculated using StepOne™ software (ver. 2.2) and DataAssist software 
(ver. 2.0). The 95% confidence interval was calculated and used for statistical 
discrimination evaluation. 
Table 5. The miRNA primers used in Paper IV 
miRNA miRNA sequence TaqMan Q-PCR primer sequence 
ssa-miR-722 UUUUGCAGAAACGUUUCAGAUU TTTTGCAGAAACGTTTCAGATT 
ssa-miR-122 UGGAGUGUGACAAUGGUGUUUG TGGAGTGTGACAATGGTGTTTG 
ssa-miR-194a UGUAACAGCAACUCCAUGUGG TGTAACAGCAACTCCATGTGG 
ssa-miR-22a AAGCUGCCAGCUGAAGAACUGU AAGCTGCCAGCTGAAGAACTGT 
ssa-miR-22b AAGCUGCCAGUUGAAGAGCUGU AAGCTGCCAGTTGAAGAGCTGT 
ssa-miR-26b UUCAAGUAAUCCAGGAUAGGUU TTCAAGTAATCCAGGATAGGTT 
ssa-miR-92a-1 UAUUGCACUUGUCCCGGCCUGU TATTGCACTTGTCCCGGCCTGT 
ssa-miR-16a UAGCAGCACGUAAAUAUUGGAG  TAGCAGCACGTAAATATTGGAG 
ssa-miR-16b UAGCAGCACGUAAAUAUUGGUG TAGCAGCACGTAAATATTGGTG 
ssa-let-7a UGAGGUAGUAGGUUGUAUAGUU TGAGGTAGTAGGTTGTATAGTT 
ssa-miR-143-1 UGAGAUGAAGCACUGUAGCUC TGAGATGAAGCACTGTAGCTC 
ssa-miR-21-1 UAGCUUAUCAGACUGGUGUUGGC TAGCTTATCAGACTGGTGTTGGC 
ssa-miR-27c UUCACAGUGGUUAAGUUCUGC TTCACAGTGGTTAAGTTCTGC 
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7 Summary of results 
7.1 Lipid analysis 
The results of changes in lipid composition as a result of different feeding diets 
in Papers I-III are presented in Table 6 as percent unit increase or decrease in 
FA compared with the average FA content in fish fed the FO diet only. The 
data are shown without detailed statistical data, but significant differences are 
indicated. Detailed statistical data can be found in the individual papers. 
In Papers I and II, the fat content in the white muscle was ~1.5% and 
~1.6%, respectively, regardless of treatment, whereas the fat content in the 
liver in Paper II increased significantly from ~5% to 7-8% in fish with the 
highest level of sesamin supplementation. 
The SAFA content in the white muscle triacylglycerol fraction in Paper I 
was lowered, but not significantly, in fish fed VO compared with fish fed FO, 
regardless of sesamin supplementation (Table 6a). In the PL fractions, there 
was an overall tendency for an increase in SAFA content when fish were fed 
the VO diet. However, there was still no clear significant increase except when 
fish were fed LO with supplementation of sesamin. In Papers I and III, the 
SAFA content in white muscle of fish fed FO and in the cell culture media was 
21.8% and 20.1%, respectively. 
In Paper II, the percentage of SAFA was significantly lower in both the 
triacylglycerol and PL fractions in liver and white muscle samples from fish 
fed VO compared with fish fed FO. The relative amount of SAFA in both 
triacylglycerols and PL fractions of the liver and white muscle of fish fed FO 
was on average 24.7%. The supplementation of sesamin to the VO diets 
decreased the amount of SAFA in the triacylglycerol fractions of both white 
muscle and liver (Table 6a) compared with an unsupplemented VO diet. In the 
liver, the amount of SAFA was lowered in a dose-dependent manner. 
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The decrease was independent of the n-6/n-3 value in the diet fed to the fish. 
Of the individual SAFA, 16:0 was most clearly affected by the addition of 
sesamin to the feed, followed by 18:0. The addition of bioactive compounds to 
the hepatocyte cell media did not affect the content of SAFA in Paper III.  
The amount of MUFA (Table 6b) in the triacylglycerol and PL fractions 
from rainbow trout white muscle samples (Paper I) fed the FO diet was 27.9% 
and 8.0%, respectively. A significant increase in the amount of MUFA was 
detected in fish fed all the different VO diets with the exception for LO (non-
significant). When sesamin was added to the feed, there tended to be an 
additional increase in MUFA content, but this effect was not significant. 
In Paper II, the MUFA content in the triacylglycerol and PL fractions for 
Atlantic salmon white muscle were 48% and 14.5%, respectively. In the liver 
the corresponding triacylglycerol and PL fractions were much higher, 51.4% 
and 32.3%, respectively. The level of MUFA in the PL fraction of the liver was 
significantly decreased regardless of n-6/n-3 ratio and sesamin 
supplementation. In contrast, the MUFA content in the PL fraction of the white 
muscle was significantly increased regardless of n-6/n-3 ratio and sesamin 
supplementation. In the triacylglycerol fractions of both white muscle and liver 
in fish fed the diet with the higher n-6/n-3 ratio, the amount of MUFA was at a 
significantly higher level than in the control fish fed FO diets. Sesamin, when 
added to the feed, significantly decreased the level of MUFA in the 
triacylglycerol fractions for the higher n-6/n-3 ratio group in both white muscle 
and liver. The results were quite different in the triacylglycerol fraction for fish 
fed the low n-6/n-3 diet, where the amount of MUFA in the liver was the same 
as in fish fed the FO diet and no effect was seen with the addition of sesamin. 
This can be compared with the significant increase in MUFA in the 
corresponding triacylglycerol fraction in fish fed the high n-6/n-3 VO feed, 
followed by a significant decrease on addition of sesamin to the diet. 
In white muscle samples from fish fed the low n-6/n-3 diet, the amount of 
MUFA in the triacylglycerol fraction was significantly decreased compared 
with fish fed the FO diet, but no increase or additional decrease was seen when 
sesamin was added. 
In Paper III, no effect was observed in the MUFA content after bioactive 
compound supplementation. 
In Paper I, the amount of LA increased in both the triacylglycerol and PL 
fractions, but the increase in the triacylglycerol fraction was twice that in the 
PL fraction. There were no significant differences in how LA was incorporated 
from the two linseed oils, but twice the amount of LA was detected in white 
muscle from rainbow trout given MO.  
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In Paper II, the amount of LA increased in triacylglycerol and PL fractions in 
both white muscle and liver samples from fish fed the VO diets (Table 6c), 
regardless of n-6/n-3 ratio, compared with fish fed FO diet. No significant 
effects were seen on LA content after incubation with sesamin, regardless of 
concentration. However, there was a trend towards high incorporation of LA 
into both white muscle and liver after diet supplementation with sesamin. 
In Paper II, the amount of LA in the triacylglycerol and PL fractions of 
white muscle from fish fed FO was 5.05% and 1.9%, respectively. The 
corresponding values in the liver were 5.71% and 2.1%. 
When FO was exchanged for VO (Paper I), the amount of ALA increased 
significantly in both the triacylglycerol and PL fractions. The amount of ALA 
measured in the triacylglycerol and PL fractions from fish fed FO was 1.37% 
and 0.61%, respectively. There were significant differences in the amount of 
ALA incorporated into white muscle of rainbow trout depending on the type of 
VO used as feed. When purified TAG was used instead of crude LO, the 
incorporation of ALA declined, and when mixed oils (MO) were used the 
incorporation of ALA into white muscle declined even further. 
The amount of ALA in the triacylglycerol and PL fractions increased in 
both white muscle and liver samples from fish fed the VO diets in all three 
studies (Table 6d). The increase was dependent on the n-6/n-3 ratio fed to the 
fish, with the percentage increase in ALA being twice as high in fish fed the 
low n-6/n-3 ratio compared with the high n-6/n-3 ratio. This was not observed 
for LA (Table 6c). In Paper II, no effects were seen on ALA composition after 
incubation of any of the bioactive compounds used. 
No effects of bioactive compound supplementation on either LA (Table 6c) 
or ALA (Table 6d) were observed in any of Papers I-III. 
On comparing the changes in EPA and DPA in Table 6e and Table 6f, it can 
be seen the amount of EPA increased in both the triacylglycerol and PL 
fractions in the liver of fish fed the VO diet, regardless of n-6/n-3 ratio (Paper 
II). When sesamin was added to the feed the amount of EPA increased 
significantly further. In contrast, EPA decreased in the white muscle samples in 
all fish fed VO and no effect of addition of sesamin was observed. Similarly, 
the amount of EPA decreased in white muscle of all fish fed VO diets in Paper 
I, regardless of VO composition. 
The DHA content decreased in all fish fed VO diets, regardless of 
treatment. There was a tendency for a greater increase in the PL fraction than 
in the triacylglycerol fraction in the white muscle of fish fed all VO diets in 
Paper I and fish fed the lower n-3/n-6 ratio in Paper II. However, this tendency 
was not statistically significant. 
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7.2 Gene expression 
An overview of the relative changes in gene expression reported as fold change 
in Papers I, II and III is given in Table 7a and 7b.  
In Paper II and III, the results were normalized against a housekeeping gene 
selected on the basis that this gene was unaffected by any of the experimental 
parameters tested. A second round of normalization was then performed 
against the control treatment (FO). The final results are presented as relative 
fold change compared with the control. In Paper I, the fold change calculations 
were similar for the liver samples tested, but for the white muscle samples no 
data were available for the fish fed FO, so the fold change data show the effect 
of sesamin supplementation on fish fed the VO diet, not the total effect of VO 
compared with the FO diet. 
In Paper I (Table 7a), different combinations of LO-based VO in 
combination with sesamin supplementation were examined. In fish fed LO or 
TAG, the effect on all genes tested was similar in white muscle. In general, the 
expression of PPARs, Δ6FAD and ACO decreased in white muscle when 
sesamin was added to the VO diet, except for the gene coding for the rate 
limiting CPT1 enzyme involved in mitochondrial β-oxidation, where the gene 
expression increased significantly compared with fish fed a strict VO diet.  
In the liver samples, changing to a VO diet in general, regardless of the type 
of VO used, resulted in increased expression of all genes tested except PPARα, 
where no effect or a small decrease was observed. On adding sesamin to the 
diet, gene expression was unaffected for PPARα and PPARγ, but increased for 
the other genes tested, in fish fed the LO diet. For Δ6FAD and ACO, the 
increase in expression after sesamin supplementation was consistent regardless 
of the type of linseed oil used, in comparison to fish fed FO and fish fed the 
VO diet. For fish fed either the TAG or MO diet, the effect of sesamin 
supplementation was limited for CPT1 compared with a strict VO diet, but 
there was still a significant increase compared with liver samples from fish fed 
FO. For PPARα, PPARβ1 and PPARγ, addition of sesamin to the diet resulted 
in a slight to significant decrease in expression for both the TAG and MO diets.  
In the experiment described in Paper II (Table 7a), no clear significant 
picture emerged for any of the transcription factors tested following sesamin 
addition. There was a general downregulating tendency among the 
transcription factors. In the case of PPARγ in Paper II, significant upregulation 
was seen when the highest concentration of sesamin was added to the high n-
6/n-3 ratio diets, while for PPARβ1A high concentrations of sesamin decreased 
the mRNA expression level, regardless of n-6/n-3 level. The exceptions were 
SREBP-1, SREPB-2 and LXR, where clear downregulation was evident in fish 
fed the low n-6/n-3 VO diet and where there was an increase in expression to 
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equal or above the levels detected in fish fed the FO diet after addition of the 
lower amount of sesamin. For fish fed the high n-6/n-3 VO diet, no clear effect 
was seen on SREBP-1 and SREPB-2 and LXR compared with fish fed the FO 
diet. Moreover, sesamin supplementation did not have any distinct effect 
except for significant downregulation of SREBP-1 when the lower 
concentration of sesamin was added to the high n-6/n-3 VO diet. 
In general, in fish fed the low n-6/n-3 ratio VO diet, genes coding for 
enzymes in the elongation and desaturation cascade showed lower expression 
than in fish fed the FO diet, except for ELOVL2 and ELOVL5b, which were 
higher in expression rate in fish fed VO. On the other hand, in fish fed the high 
n-6/n-3 diet, the same set of genes was generally significantly upregulated 
compared with fish fed the FO diet. In most cases the lower concentration of 
sesamin increased the expression of genes coding for enzymes in the 
elongation and desaturation cascade. The exceptions were ELOVL5a, 
ELOVL5b and ELOVL4, which showed no effect or significant downregulation 
when sesamin was added to the high n-6/n-3 VO diet.  
The effects of the different bioactive compounds (Paper III) were more 
apparent after 48 hours of incubation (Table 7b). In general, sesamin, 
episesamin and LPA increased the expression of ∆5FAD, ∆6FAD, ELOLV2, 
ELOLV5a, CD36, CPT-1 and ACO. Sesamin also increased PPAR1β and 
PPARγ and episesamin increased PPARα and PPAR1β. Incubation with LPA 
for 12 hours increased the expression of all PPAR, but further incubation for 48 
hours decreased the expression of PPARα and PPAR1β. During the same 
incubation period, LPA significantly increased PPARγ transcription. 
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7.3 miRNome analysis of liver in mature Atlantic salmon 
Total RNA from the liver from six mature individuals at the post-smolt 
developmental stage was extracted, size-separated and successfully subjected to 
NGS using the Illumina® HiSeq™ 2000 Sequencing System. Roughly 45 million 
reads were obtained and of these, 41 million or 90.2% were annotated against the S. 
salar miRBase, roughly 1.5% were annotated against zebrafish (Danio rerio) and 
8.29% remained unannotated (Figure 7).  
 
Figure 7. Percentage distribution of the 45 million expression reads generated from the liver of fully 
grown Atlantic salmon (Salmon salar) post-smoltification, divided into reads with a perfect match, 
reads with one mismatch and reads with two mismatches against annotated miRNAs in S. salar and 
homologues miRNAs in zebrafish (Dario rerio), as well as remaining annotated reads. 
In total, 229 distinct conserved miRNAs (or 159 miRNA families) were identified 
(Paper V), not counting the isomiRs. According to recommendations by Ambros et 
al. (2003) and Griffith-Jones et al. (2006), the dominant strand must have 10 or 
more reads to ensure it is not a transcription error. In the material tested, 92 
sequences had an abundance below 10. Thus in total, in Paper V we identified 22 
conserved miRNAs with high abundance and 137 low abundance conserved 
miRNAs (Supplementary Table S3 in Paper V), as well as a considerable amount of 
new isomiRs (Supplementary Table S4 in Paper V). Of the 159 conserved miRNAs 
identified, 30 were novel conserved miRNAs previously annotated for other 
vertebrates in miRBase (Table 8). 
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A total of 779 471 small distinct RNA tags were found and of these 4.6% were 
annotated against S. salar entries corresponding to 369 of the 371 existing entries 
(Figure 8A). The two miRNAs not represented were ssa-miR-219c and ssa-miR-
7552a. Of the 369 entries annotated against S. salar, 316 (red bars) were also found 
in D. rerio, 244 in Ictalurus punctatus (channel catfish) and so on. Of the 743 615 
unannotated RNA tags that remained after screening against the S. salar miRNA 
library, an additional 293 were identified as putative orthologues miRNAs annotated 
against D. rerio, 244 against I. punctatus etc. (yellow bars in Figure 8). 
 
 
Figure 8. Number of conserved miRNAs and isomiRs identified (red bars) corresponding to published 
S. salar miRNA entries in MiRBase version 21 (blue bars), and the additional number of putative 
miRNAs identified in the unannotated set after screening against S. salar (green bars) in: A) orthologues 
from other teleost species and B) orthologues from humans, mice and rats. 
The residual 95.4% or 743 622 tags remained unannotated. The unannotated tags 
were once more BLAST-searched and mapped against the published miRNAs in 
miRBase. The identified miRNAs cover a large proportion of reported miRNAs in 
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Pisces, including zebrafish, common carp (Cyprinus carpio), Atlantic halibut 
(Hippoglossus hippoglossus), torafugu/Japanese pufferfish (Fugu rubripes), channel 
catfish, medaka/Japanese rice fish (Oryzias latipes), olive flounder (Paralichthys 
olivaceus) and green spotted puffer fish (Tetraodon nigroviridis) (Figure 8A), 
compared with a rather low representation of the published miRNAs belonging to 
humans (Homo sapiens), mice (Mus musculus) and rats (Rattus norvegicus) (Figure 
8B). In Paper V the overlap of the miRNA sequences identified was compared with 
those identified or predicted in earlier studies of Atlantic salmon and rainbow trout, 
since not all miRNA sequences have been entered into MiRBase ver. 21 
(Andreassen et al., 2013; Bekaert et al., 2013; Barozai, 2012; Ma et al., 2012; 
Salem et al., 2010; Ramachandra et al., 2008). The data proved to be consistent with 
previous miRNA annotation for S. salar. 
All miRNAs with an individual abundance above 0.50% (Figure 9) and with 
over 1000 copies of each isomiR are listed in Supplementary Table 4 in Paper V. 
Star In total, 22 miRNAs had an abundance above 0.5%. Moreover, 43 new isomiRs 
were identified, of which two were isomiRs of the sequence (ssa-miR-100-3p and 
ssa-miR-130-5p). Two new precursors (ssa-miR-126 and ssa-miR-130) were also 
identified. Three miRNAs (ssa-miR-722, ssa-miR-126 and ssa-miR-143) did not 
have any variants in the material tested. 
 
Figure 9. Relative presence of the most common miRNAs in mature liver samples, as a function of 
expression values. 
The relative abundance of miRNAs varied greatly among the conserved miRNAs 
(Figure 9). The most abundant miRNAs included ssa-miR-122, ssa-let-7, ssa-miR-
16, ssa-miR-22, ssa-miR-21, ssa-miR-199, ssa-miR-722, ssa-miR-100, ssa-miR-126, 
ssa-miR-20, ssa-miR-130, ssa-miR-26, ssa-miR-451, ssa-miR-15, ssa-miR-181, ssa-
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mir-143 and ssa-miR-194, which accounted for ~91% of the 41 682 086 reads 
mapped to miRBase. Of the ssa-let-7 family, ssa-let7a, ssa-let7e and ssa-let7j were 
the most abundant.  
We also identified 30 novel conserved miRNAs which were homologues to 
miRNA annotated in MiRBase but not previously described in Atlantic salmon 
(Table 8). Of these novel conserved miRNAs identified, the majority were low 
abundant (below 0.5%) except for ssa-miR-451, which was highly abundant with a 
presence of 1.43%. Two isoforms of ssa-miR-451 were identified, where omy-miR-
451a has been annotated previously in rainbow trout. However, the isomiR ssa-miR-
451b was by far the most dominantly expressed, with three-fold higher expression 
than ssa-miR-451a. Ssa-miR-451a and ssa-miR-451b were found to be highly 
conserved when aligned against previously annotated miR-451 in miRBase (Figure 
10).  
 
Figure 10. Alignment of the novel conserved miRNA miR-451 against orthologous entries in MiRBase 
version 21. Comparison of two novel conserved isomiRs (ssa-miR-451a and ssa-miR-451b) differing 
only in one single nucleotide in the mature miRNA (marked with a red box). No difference can be seen 
in hairpin loop structure. 
Of all conserved miRNAs found in the mature liver samples, 79.91% were located 
on 5′stem and 18.16% on 3′stem when the evaluation was based on individual 
transcription rate data for the whole population. However, of the 22 highest 
expressed mature miRNA, 12 were located on the 5′strand and 10 on the 3′strand. 
Both ssa-miR-122 and ssa-let-7 had a mature 5′strand and these two miRNAs 
covered more than 57% of all transcribed miRNAs in mature liver of Atlantic 
salmon.  
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7.4 Evaluation of miRNA endogenous controls 
Similarly to mRNA expression analysis, miRNA qPCR analysis requires 
thoroughly investigated endogenous controls. In Paper IV the expression of 
ssa-let-7a, ssa-miR-16a, ssa-miR-16b, ssa-miR-194a, ssa-miR-22a, ssa-miR-
22b, and ssa-miR-27c was examined with regard to their use as endogenous 
controls in microRNA expression studies. The ideal endogenous control genes 
should be expressed on a constant level in different tissues, regardless of 
developmental stage and unaffected by experimental treatment. The most 
suitable endogenous control was ssa-miR-27c. 
7.5 Tissue distribution of selected miRNAs 
In Paper IV, the distribution of selected miRNAs in nine somatic tissues (liver, 
heart, brain, kidney, spleen, intestine, gill, white, and red muscle) was 
evaluated. The majority of the miRNAs tested were highly tissue-specific. 
Some miRNAs were only expressed in one tissue. For example, ssa-miR-122, 
ssa-miR-722 and ssa-miR-92a were almost exclusively expressed in the liver 
and ssa-miR-16a and ssa-miR-21 were only expressed in the brain. Both ssa-
miR-143 and ssa-let-7a were expressed in the kidney, but showed preferential 
expression in gills and red muscle, respectively.  
The different isomiRs showed distinct differences in transcription levels 
and tissue specificity. As mentioned previously, ssa-miR-16a was brain-
specific but ssa-miR-16b showed high levels of expression in the brain but also 
in the liver, red muscle and kidney. The expression of ssa-miR-16a tended to 
be higher than that of ssa-miR-16b, but the difference was not significant. 
Similarly, ssa-miR-22a was predominantly expressed in liver, red muscle and 
stomach, whereas ssa-miR-22b showed a much lower expression rate overall 
and was more evenly expressed between tissues except for no detectable levels 
in gills and white muscle.  
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8 General discussion 
The objective of this thesis was to determine the effect of adding bioactive 
compounds both in vivo and in vitro on the expression of genes related to lipid 
homeostasis in salmonids. 
The main aim was to investigate the underlying molecular mechanisms of 
n-3 LCPUFA biosynthesis and regulation in salmonids. The overall objective 
was to deliver a comprehensive map of miRNAs expressed in the liver of 
mature Atlantic salmon and identify novel liver-predominant miRNAs. The 
intention was for the knowledge acquired to be used in future guidance on how 
to optimize the content of n-3 LCPUFA in salmonids through enhanced 
activity of the desaturation and elongation pathway, thus enabling efficient and 
effective use of VO in aquaculture while maintaining the high nutritional 
quality of wild catch fish. 
8.1 Effects on growth performance 
Replacement of FO with VO did not affect growth performance in Papers I and 
II, which confirms previous findings for Atlantic salmon (Torstensen et al., 
2005a; Bell et al., 2001; Torstensen et al., 2000) and rainbow trout (Trattner et 
al., 2008a).  
Addition of sesamin had a dose-dependent negative effect on growth in 
Paper II, but only the highest inclusion rate resulted in significantly reduced 
final weight. This is contradictory to growth performance results in studies 
resting sesamin inclusion in the feed of Atlantic salmon (Trattner et al., 2011), 
rainbow trout (Trattner et al., 2008a) and carp (Mraz et al., 2010). However, 
similar results have been obtained in trials on juvenile barramundi (Lates 
calcarifer), where the growth rate was reduced in fish receiving sesamin, 
regardless of the dietary oil used (Alhazzaa et al., 2012). The reduction in 
growth observed in this thesis with the addition of a high sesamin content is in 
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agreement with studies of other bioactive compounds, e.g. dodecylthioacetic 
acid and tetradecylthioacetic acid (TTA) (Kleveland et al., 2006a) Moya-
Falcón et al., (2004), where these substances significantly lowered the body 
weight of Atlantic salmon.  
8.2 Effects on lipid content 
8.2.1 Total lipid content 
In the in vivo study in Papers I and II, the white muscle lipid content was not 
affected by sesamin supplementation. However, in Paper II the liver fat content 
was significantly increased by addition of the high level of sesamin, 
confirming previous findings in rats (Ashakumary et al., 1999). This is 
contrary to results obtained by Moya-Falcón et al. (2004), where the liver lipid 
content was reported to be unaffected by the addition of TTA to Atlantic 
salmon diets. In another study, addition of conjugated linoleic acid or TTA did 
not affect the total amount of lipids in liver of Atlantic cod (Gadus morhua) 
(Kennedy et al., 2007b). 
8.2.2 Fatty acid composition 
As expected, the composition of FAs in white muscle and liver strongly 
reflected the FA composition in the different diets in both rainbow trout and 
Atlantic salmon. For example, in Paper II the amount of MUFA in the TAG 
fraction was significantly higher in both white muscle and liver from fish fed 
the VO diet with the high n-6/n-3 compared with the control fish fed FO diets, 
as a consequence of the significantly higher amount of MUFA in the VO feed. 
Increased levels of LA and ALA were also observed as an effect of VO 
inclusion compared with FO in both rainbow trout and Atlantic salmon. In 
addition, the ALA content was lower in white muscle of rainbow trout fed the 
MO diet compared with the LO and TAG diets, reflecting the composition of 
the different diets in Paper I. Similarly, replacement of FO with VO reduced 
the proportion of DHA in both white muscle (Paper I) and white muscle/liver 
(Paper II). In Paper II, the two different n-6/n-3 ratios had an impact on n-3 FA 
content in fish, with the higher ratio mainly resulting in lower amounts of 
ALA. This decrease was not reflected in higher percentages of DHA and EPA. 
These results are in agreement with several studies where complete or partial 
replacement of FO with VO, such as rapeseed oil, palm oil, LO and/or soy oil, 
had a significant effect on lipid composition in salmonids (Pettersson et al., 
2009; Turchini & Francis, 2009; Jordal et al., 2007; Torstensen et al., 2005b; 
Bell et al., 2001; Thomassen & Røsjø, 1989), lowering the proportion of DHA 
in both liver and muscle.  
74 
In Paper I, fish fed the TAG diet, where the polar phase had been removed, had 
a higher proportion of EPA and lower proportion of ALA in triacylglycerol 
fraction and an increased level of DPA in the PL fraction compared with the 
LO diet. These results could indicate that the polar fraction removed from the 
LO had some effect on the metabolism of PUFA. No additional effect of 
sesamin supplementation on FA composition was observed. However, in the 
triacylglycerol fraction of the LO+sesamin group, ALA was significantly 
decreased compared with the LO group, but no corresponding increase was 
seen in DHA content.  
No effect of sesamin supplementation was seen in the amount of ALA or 
DHA in Paper II or Paper III. This contradicts previous studies, where a 
significant increase in DHA has been observed on addition of a dietary 
sesamin/episesamin mixture in both white muscle of rainbow trout (Trattner et 
al., 2008a) and in Atlantic salmon hepatocytes (Trattner et al., 2008b). 
However, sesamin addition affected the FA involved in the synthesis of DHA, 
e.g. 20:3n-3 increased and EPA and DPA decreased in white muscle in Paper 
II. In contrast, an increase in EPA and a very limited effect to slight decrease in 
DPA were seen in the liver after sesamin supplementation.  
The difference in response to bioactive compounds compared with 
previously published results may be explained by several factors. First of all, 
the physiological response to bioactive compounds may vary depending on fish 
species. Seawater fish have a lower capacity to convert ALA to DHA than 
freshwater fish (Sales, 2010; Sargent & Tacon, 1999). However, in Papers I-III 
no distinction in response to sesamin was apparent between rainbow trout 
(Paper I) and Atlantic salmon (Papers II and III).  
Within-species variations in the response to bioactive compounds may 
depend on age, gender, size and possibly environmental conditions such as 
temperature and feed composition. It has been shown that the synthesis of 
DHA decreases with size/age in Atlantic salmon (Zheng et al., 2004). In Paper 
III, the fish were fed a commercial FO-based diet before sacrification and 
hepatocyte preparation. This diet is particularly high in n-3 LCPUFAs. The 
individual fish used in the experiment were therefore well nourished and had a 
high fat content. There were clear differences in age and size between fish in 
Papers I, II and III compared with the studies performed by Trattner et al. 
(2008a); (Zheng et al., 2004) (final weight; ~88 g, ~105 g and ~1300 g, 
respectively, compared with ~35 g), which probably had an effect on the final 
results. 
The feeding period can also affect physiological response to sesamin. In 
Paper II, the experimental diets were fed to fish for four months, which is 
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longer than in previous studies (5-11 weeks) (Trattner et al., 2011; Mraz et al., 
2010; Trattner et al., 2008a; Trattner et al., 2008b).  
Another possible reason for the lower effect on DHA in Papers I and II is 
that only sesamin was used, whereas an equimixture of sesamin and 
episesamin was used by Trattner et al. (2011; 2008a). Episesamin is reported to 
be a stronger lipid modulator of enzyme activity than sesamin in mammals 
(Kiso et al., 2005; Kushiro et al., 2002). Therefore, the presence of episesamin 
in the diet of fish may be important for modulation of FA composition.  
8.3 Effects on lipid-related gene expression 
As reported in previous studies, inclusion of VO as a natural consequence 
affected the expression of lipid-related genes (Torstensen et al., 2009; Trattner, 
2009; Leaver et al., 2008a).  
In Papers I and II, the reduction in dietary n-3 LCPUFA in favor of 
increased levels of n-3 MUFA and ALA resulted in alteration in expression of 
genes related to FA β-oxidation (CPT1 and ACO) and PPAR, but the data were 
not consistent. The increased levels of FAs involved in PUFA synthesis and the 
increased expression of the genes involved observed in Papers I and II support 
the claim that sesamin has an impact on lipid metabolism.  
In Paper III, where salmon hepatocytes were incubated with different 
bioactive compounds, only small effects were seen in the FA profile. The 
effect on the gene expression profile was more pronounced. After 48 hours of 
incubation with LPA, episesamin or sesamin, upregulation of all the genes 
chosen as markers (ELOVL5a, ∆5FAD, ELOVL2 and ∆6FAD) for the 
biosynthesis of PUFAs was observed.  
As previously mentioned, episesamin has been shown to be more potent 
than sesamin. In Paper III, there were differences in CD36 and CPT1, where 
the expression was more upregulated with episesamin than sesamin. In 
contrast, the expression of PPARγ was higher in the sesamin-treated than 
episesamin-treated cells. In general, the results in Paper III suggest a time-
dependent response regardless of the bioactive compound added to the 
medium, with more pronounced effects after 48 hours. Individual bioactive 
compounds generated different effects.  
In view of the whole genome duplication event that occurred in the 
evolution of salmonids (Allendorf, 1978), gene expression studies are complex 
due to the presence of duplicate genes that may be differently regulated. In 
addition, the individual fish tested in Papers I-V were not genetically 
homogeneous or offspring from one single genetically identical family. It can 
be assumed that there was genetic variation between individual fish both within 
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trials and between replicates from each tank, which may have affected the 
experimental outcome. One solution to decrease this variation would be to 
increase the number of individuals. A greater number of replicates would 
influence the statistic reliability, the correlation between FA composition and 
gene expression results in these supplementation studies. This is exemplified 
by the work done on SNP allele frequency studies using pyrosequencing 
(Wasson et al., 2002), which shows that doubling the sample size drastically 
improves the detection accuracy.  
8.3.1 Uptake of fatty acids 
Markers for FA uptake (CD36 and SR-B1) were only tested in Papers II and III. 
Both PPARα and PPARγ have been shown to induce the transcription of CD36 
and SR-B1 (Torstensen et al., 2009; Malerød et al., 2005; Malerød et al., 2003; 
Poirier et al., 2001; Motojima et al., 1998), so it was not surprising that the 
effects on these genes were limited. No effects were seen on SR-B1 in Paper II 
and CD36 only showed significant downregulation in tissues from fish fed the 
higher dietary ratio of n-6/n-3 with sesamin added. No effects were seen on 
either PPARα or PPARγ in Paper II.  
In Paper III, the expression of CD36 followed the same expression pattern 
as PPARγ in all treatments after 48 hours, but the trend was not as clear for 
PPARα. After 48 hours, expression of CD36 was upregulated following 
incubation with episesamin, sesamin and LPA for 12 and 48 hours. Similarly, 
in Paper III expression of PPARα was related to expression of the long chain 
FA transporter, CD36 in LPA (12 h), genistein 0.005mM (48 h) and 
episesamin (48 h). The effect of episesamin was twice as high as that of 
sesamin. This finding is in agreement with Kushiro et al. (2002), who reported 
more potent effects of episesamin than sesamin.  
8.3.2 Elongation and desaturation 
The transcription rate of all elongases except ELOVL5a was increased in the 
liver of salmon fed VO, irrespective of n-6/n-3 ratio, compared with that of fish 
fed the FO diet. This is in line with Morais et al. (2009), who reported that 
expression of ELOVL5b and ELOVL2, but not of ELOVL5a, was significantly 
increased in both liver and intestine when Atlantic salmon were fed VO instead 
of FO. ELOVL5b codes for genes involved in the elongation of C18 to C20 
PUFA and ELOVL2 for genes involved in the elongation of C20 to C22 
(Morais et al., 2009; Hastings et al., 2004). SREBP-1 and SREBP-2 were only 
evaluated in Paper II, but expression was significantly increased by the lower 
addition rate of sesamin to the low n-6/n-3 ratio diets. In fish fed these diets, 
the SREBP target genes, desaturases and elongases were also all significantly 
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upregulated. This is in agreement with hepatocyte studies in rodents, where the 
expression of ELOVL5, ∆6FAD and ∆5FAD has been shown to be regulated by 
both PPARα and SREBP-1c (Qin et al., 2009; Matsuzaka et al., 2002). Paper II 
showed increased expression of SREBP, elongases and desaturases, but not of 
PPARα. The increase in ELOVL5b and ELOVL2 in fish fed the VO diet (V0.5) 
with low sesamin addition was accompanied by a non-significant increase in 
the amount of DHA in both the TAG and PL fractions. Expression of 
desaturation and elongation genes increased significantly with addition of 
sesamin. The effect of sesamin seemed to be influenced by the FA composition 
and n-6/n-3 ratio in the VO formulation (Papers I and II). For the lower n-6/n-3 
ratio, sesamin increased desaturation and elongation, while for the higher n-
6/n-3 ratio, sesamin decreased both desaturation and elongation. This is similar 
to results reported by Trattner et al. (2008b). In Paper II, fish fed the V0.5SL 
and V0.5SH diets showed increased expression of LXR compared with fish fed 
the V0.5S0 diet (see Table 1 for diet abbreviations). This could indicate that 
sesamin acts on SREBP-1c directly, or indirectly by activation of LXR. The 
increased expression of LXR and SREBP can also be related, since LXRα and 
LXRβ have been shown to activate SREBP-1c in rodents (Cruz-Garcia et al., 
2009; Zhou et al., 2008).  
After 12 hours of incubation, ∆5FAD showed significant downregulation in 
cells incubated with genistein 0.005mM, LPA and sesamin. However, the 
expression of both ∆6FAD and ∆5FAD was upregulated by episesamin, 
sesamin and LPA after 48 hours. There were striking and rapid changes in 
∆5FAD gene expression, from pronounced downregulation to upregulation, 
with genistein 0.005mM, LPA and sesamin. The upregulation of desaturases 
after 48 hours of incubation with sesamin contradicts results obtained by 
Trattner et al. (2008a), where downregulation of both ∆6FAD and ∆5FAD was 
detected after incubation with sesamin. However, the downregulation of the 
desaturases was seen in combination with an increased amount of radio-
labelled DHA synthesised from 14C 18:3n-3 (Trattner et al., 2008a). In Paper 
III, no significant effects were observed on DHA levels, but there were effects 
on stearidonic acid (18:4n-3) and 20:4n-3, possibly due to differences in fish 
size.  
Desaturase and elongase activities, gene expression and, consequently, the 
response to treatment may depend on how fatty the individual fish was at the 
time of sampling. The fish used in Paper III were fatter than those in the study 
by Trattner et al (2008a). For further studies, determining the weight and 
length relationship could be interesting and helpful in understanding the 
metabolism of lipids. Furthermore, in the previous study radio-labelled FA was 
used, whereas Paper III total FA were analyzed and some changes could have 
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been masked by the endogenous pool of FA. In addition, consideration should 
be given to the feed the fish were fed prior to hepatocyte isolation, since the 
fish in Paper III were fed a commercial diet high in n-3 LCPUFA, which is 
known to inhibit enzymes involved in the elongation and desaturation cascade 
(Tocher et al., 2003a). In contrast, a rapeseed oil-based diet prior to hepatocyte 
isolation increases enzyme activity of ∆5FAD, ∆6FAD and elongases (Moya-
Falcón et al., 2005). A possible interaction between feed FA composition and 
content of bioactive compound could explain the different results between the 
groups in present studies. The lack of correlation between desaturase 
expression and LCPUFA biosynthesis may also indicate that the effect of 
sesamin was mediated through other mechanisms not yet understood.  
8.3.3 β-oxidation 
In Paper I, the reduction in dietary n-3 LCPUFA in favor of increased levels of 
n-3 MUFA and ALA, resulted in alteration in expression of genes related to 
FA β-oxidation and PPAR. Sesamin had a weak to clear downregulating effect 
on PPARα expression in liver of fish fed any of the three VO tested, which 
confirms findings by Trattner et al. (2008a) that expression of PPARα is 
significantly downregulated in the liver of rainbow trout fed 
sesamin/episesamin as a supplement to a mixed oil diet. The same 
downregulation was seen in white muscle for fish fed the LO and TAG diets.  
No significant effect was seen on PPARα after sesamin addition to the diet 
in Paper II or to the media in Paper III. Since PPARα is considered to be the 
main inducer of β-oxidation (Leaver et al., 2006), a corresponding 
downregulation in the β-oxidation markers could be expected. However, the β-
oxidation markers tested, CPT1 and ACO, were significantly upregulated in 
both fish fed VO diets and fish given sesamin supplementation in Paper I. 
PPARβ/δ and PPARγ have also been shown to target the genes coding for the 
β-oxidation enzymes, CPT1 and ACO, in liver and white muscle of rainbow 
trout and Atlantic salmon (Torstensen et al., 2009; Du et al., 2004; Ruyter et 
al., 1997). In Papers I and III, both PPARβ/δ and PPARγ followed the same 
expression pattern as CPT1 and ACO. One could speculate that the effect of 
sesamin is not caused by ligand binding to the PPARα. Cloning analysis of the 
ligand-binding regions of PPARα and PPARγ genes in Atlantic salmon have 
revealed that they contain additional amino acid residuals, which could suggest 
that the ligand-binding properties in salmon PPARs differ from those seen in 
rodents (Andersen et al., 2000). This could explain the deviation from findings 
in rodents (Ashakumary et al., 1999). 
The upregulation of β-oxidation markers is in agreement with a previous 
study by our research group, which showed increased levels of β-oxidation 
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products after addition of sesamin to Atlantic salmon hepatocytes (Trattner et 
al., 2008a) and in studies on rodents (Jeng & Hou, 2005; Ashakumary et al., 
1999). In the low n-6/n-3 ratio groups in Paper II, similar results were found 
for ACO, but not for CPT1. However, in that study both ACO and CPT1 were 
significantly downregulated after high sesamin addition in the high n-6/n-3 
ratio diet. This might indicate that the n-6/n-3 ratio influenced the response of 
β-oxidation genes to sesamin. 
After 12 hours of incubation in Paper III, PPARγ was upregulated in the 
genistein 0.005mM treatment and increased mRNA levels for β-oxidation 
markers were seen. These findings agree with previous reports that genistein is 
effective in increasing the activity of enzymes involved in β-oxidation in 
rodents (Takahashi et al., 2009) and that it acts in the same manner as fibrates, 
known agonists of PPARα, in both in vivo and in vitro studies in rodents 
(Ricketts et al., 2005) and as a ligand for PPARγ (Dang et al., 2003). 
All three PPARs and markers for β-oxidation were upregulated in response 
to 12 hours of incubation with LPA addition to the hepatocyte media. 
Similarly, in a study on rodents LPA also increased β-oxidation (Huong & Ide, 
2008). This indicates that LPA can activate the different PPARs and thereby 
trigger the expression of target genes for mitochondrial β-oxidation. 
8.4 Feedback regulation 
A surplus of n-3 LCPUFA in salmonid feed prior to a shift in dietary oils has 
been shown to reduce the capacity of salmonids to swiftly increase the 
synthesis of n-3 LCPUFA when the oil in the aquafeed is changed from FO to 
VO (Moya-Falcón et al., 2005; Tocher et al., 2003a). Furthermore, Tocher et 
al. (2003b) demonstrated a significant correlation between the activity of the 
LCPUFA biosynthetic pathway and dietary n-3 LCPUFA levels. PUFAs 
suppress expression of lipogenic genes and induce expression of PPARs, which 
simultaneously induce the transcription of genes encoding proteins of lipid 
oxidation and thermogenesis (Price et al., 2000). 
In Paper III, the fish were fed commercial FO based diet prior to dissection 
and hepatocytes preparation. Commercial FO based is high in n-3 LCPUFAs. 
The individual fish used in the experiment had equal condition factor and high 
fat content. Even though the amount of EPA and DHA was low in the 
hepatocyte culture media, it is likely that the feeding conditions prior to 
slaughter, with high levels of both EPA and DHA, could have influenced the 
potential positive effect of bioactive compounds on the process of desaturation, 
elongation and β-oxidation. This suggestion is supported by data presented by 
Henderson & Sargent (1984), which show that peroxisomal β-oxidation is 
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increased only when there is an imbalance between the amount of MUFA 22:1 
and PUFAs, a situation which is very unlikely to occur in natural fish diets or 
in standard FO diets. 
Negative feedback regulation at the transcriptional level (Figure 11) is one 
of the most common motifs in gene regulatory networks (Zeron & Santillán, 
2010).  Tocher et al. (2003a) and Nakamura & Nara (2004), among others, 
have suggested that ∆5FAD and ∆6FAD are regulated by a negative feedback 
loop and that excessive intake of LA, ALA or any other type of PUFA can be a 
problem, leading to suppression of the PUFA metabolic pathway.  
 
Figure 11. Schematic representation of a gene expression system subject to negative feedback 
regulation, where a decrease in amount of metabolite below a certain level sends a signal back to 
the promoter region of the gene in question, resulting in triggering of mRNA transcription. 
(Modified after Zeron & Santillán, 2010). 
Thomassen et al. (2012) showed that when EPA and DHA were added to a 
rapeseed oil diet, the total process of desaturation, elongation and β-oxidation 
to DHA was significantly reduced (by about 50%) in Atlantic salmon. In vitro 
studies indicate that the inhibition is triggered by DHA and not by EPA 
accumulation. The inhibition occurred mainly at the ∆6 desaturation step from 
24:5n-3 to 24:6n-3, and at the second elongation step (ELOVL2) from DPA to 
81 
24:5n-3. From this, it can be postulated that FO actually suppresses the 
desaturation and elongation of LCPUFAs.  
    Figure 12 summarizes the different regulation alternatives in the desaturation 
and elongation process of LCPUFAs. It is likely that not one but several 
regulation pathways are involved in the desaturation and elongation cascade. 
The first and conventional alternative for feedback inhibition (step I in Figure 
12) is a high level of the metabolite (in this case DHA) directly inhibiting the 
transcription of DNA to mRNA, with an associated decrease in mRNA 
expression as the end result. If this mode of action dominated, in the current 
situation we would expect a decrease in gene expression of ∆5FAD, ∆6FAD, 
ELOVL5 or ELOVL2, followed by a decrease in enzyme activity and finally a 
decrease in amount of DHA. 
The second alternative is post-transcriptional regulation or RNA silencing 
(step II in Figure 12). Here, no inhibition needs to be seen on the mRNA level, 
but ultimately a decrease in the amount of expressed protein/enzyme. In some 
cases it may even be possible to detect an increase in mRNA expression. In 
step III in Figure 12, the feedback mechanism inactivates the ∆5FAD or 
∆6FAD desaturase and/or ELOVL5 or ELOVL2 elongase, generating no end 
product (DHA).  
 
Figure 12. Schematic representation of four possible negative feedback regulation mechanisms in 
fish rich in EPA and/or DHA. 
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In a final alternative, the feedback mechanism could target other target genes 
or genes coding for transcription factors with effects on that particular gene 
expression as the primary effect, e.g. decreased expression of PPAR or SREBP 
(step IV in Figure 12). 
The turnover of mRNA is extremely sensitive to dietary changes, resulting 
in fluctuations in mRNA levels, which in Papers I-III did not generate 
equivalent variations in the FA composition. Such fluctuations could indicate 
that using mRNA analysis as the only measurement, without considering 
potential post-transcriptional regulation mechanisms, protein levels or enzyme 
activity measurements, is a limited tool to explain biochemical results. 
8.5 Epigenetic regulation 
It is possible that the unlimited excess of n-3 LCPUFA in salmonid feed for 
generations of both wild fish and fish in aquaculture can be under epigenetic 
regulation and is the cause of the reduced capacity in salmonids to swiftly 
increase synthesis of n-3 LCPUFA when the oil in the aquafeed is changed 
from FO to VO.  
During recent decades the picture of gene regulation has become still more 
complex with the discovery of epigenetic regulation. The four major 
components of epigenetic regulation are promoter methylation, histone 
modification, chromatin conformation changes and altered expression of non-
coding RNAs, especially miRNAs. 
8.6 MicroRNA regulation in liver of Atlantic salmon 
The discrepancy between increased expression of target genes in the 
desaturation and elongation cascade and the lack of an actual response in the 
FA content of EPA and DHA is most likely the result of a combination of 
feedback regulation and post-transcriptional regulation such as RNA silencing. 
However, this needs to be verified and one step towards this is mapping of the 
expression of different miRNAs in the liver of Atlantic salmon.  
8.6.1 Identification of hepatic miRNA 
At present, more than 28 645 entries have been made in miRBase version 21 
(June 2014) representing hairpin precursor miRNAs, expressing 35,828 mature 
miRNA products annotated in 223 different species (Griffiths-Jones et al., 
2006). The number of known fish miRNAs is not comparable to those for 
human and mouse, considering the conserved nature of miRNAs among 
different species. For a long time, the miRNAs identified were limited to 
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model species such as zebrafish (Mishima, 2012; Kloosterman et al., 2006; 
Schier & Giraldez, 2006), tiger blowfish, Medaka (Li et al., 2010a) and green 
spotted puffer. The miRNAs identified in non-model species were limited to 
rainbow trout (Salem et al., 2010; Ramachandra et al., 2008), Atlantic halibut 
(Bizuayehu et al., 2012) and Atlantic cod (Johansen et al., 2011; Johansen et 
al., 2009), and were identified using more or less extensive direct cloning, 
sequencing and northern blot analyzes. However, there are some restrictions to 
these methods, such as their limited capability to detect low abundant miRNAs 
and therefore mainly uncovering conserved miRNAs (Ruby et al., 2007; Ruby 
et al., 2006). This can partly explain the limited number of miRNAs detected 
in teleosts.  
The introduction of the NGS platforms has made it possible to precisely 
identify and characterize non-conserved or low expressed miRNAs in Atlantic 
salmon and rainbow trout (Andreassen et al., 2013; Bekaert et al., 2013; Ma et 
al., 2012). Depending on the experimental set-up, NGS technologies can 
provide more complete view of the miRNA transcriptome (miRNome), 
including identification and quantification of both highly abundant conserved 
miRNA and non-conserved or low abundance miRNA, spanning nearly six 
orders of magnitude of expression (Morin et al., 2008). 
While the interaction of the miRNA and liver transcriptome had been well 
established in mammals  (Nan et al., 2013; Gatfield et al., 2009b; Girard et al., 
2008; Varnholt, 2008), the importance of post-transcriptional regulation 
through miRNA intervention on diverse metabolic processes in salmonids 
remains to be determined. This thesis presents the first deep sequencing results 
for the miRNome in liver of Atlantic salmon, and provides a basis for further 
studies on post-transcriptional regulation of hepatic lipogenesis and 
homeostasis. 
In this thesis, 159 conserved previously described miRNA families 
(Andreassen et al., 2013; Bekaert et al., 2013; Ma et al., 2012) were annotated 
in Atlantic salmon liver, of which ssa-miR-122 was by far the most abundant 
miRNA, with a presence of 48%. It has been reported that miR-122 is a highly 
abundant conserved liver-specific miRNA, with e.g. over 72% of all miRNA 
molecules present in mouse hepatocytes being variants of miR-122 (Lagos-
Quintana et al., 2002). However, this is probably somewhat of an overestimate, 
since the results were achieved using tissue-specific cloning, which generates 
far more limited statistical material than NGS, although miR-122 is clearly 
highly abundant. Studies in mammals have shown that miRNA-122 is 
implicated together with transcription factor HNF6 in the differentiation and 
maintenance of the hepatic phenotype (Laudadio et al., 2012; Jung et al., 2011; 
Xu et al., 2010) and the regulation of lipid metabolism (Girard et al., 2008; 
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Esau et al., 2006a; Krützfeldt et al., 2005). Gatfield et al. (2009) also showed 
that REV-ERBα, the major circadian regulator in mammals, regulates the 
expression of miR-122. In turn, miR-122 participates in the circadian control of 
genes in hepatic metabolism through the miR-122 targets PPARβ/γ and 
SMARCD1/BAF60a, which is a coactivator of PPARα. In rainbow trout, omy-
miR-122 has also been linked to the regulation of cholesterol and lipid 
metabolism, but the results indicate that the metabolic consequences of omy-
miRNA-122 inhibition differ quantitatively between vertebrate species and that 
distinct direct molecular targets of miRNA-122 may mediate different 
metabolic effects depending on vertebrate species (Mennigen et al., 2014a; 
Mennigen et al., 2014b).   
The second most abundant miRNA family found in Atlantic salmon in this 
thesis was ssa-let-7, which is probably the best-known highly conserved 
miRNA and functions as the key regulator of developmental timing in almost 
all animal species (Bartel, 2009; Ambros, 2001). 
All of the 13 distinct novel miRNAs discovered by Andreassen et al. (2013) 
were identified. However, none of these 13 novel miRNAs had a presence 
above 0.3‰. Even the novel ssa-miR-8163 was present with a low number of 
reads (7 425). This was somewhat unexpected, since differential expression 
data from Andreassen et al. (2013) suggested that this miRNA should be 
enriched in liver tissue. A reason for this could be that ssa-miR-8163 has a 
different role in the post-smolt Atlantic salmon mature liver than in the pre-
smolt and one-day-old individuals tested by Andreassen and co-workers. 
In this thesis, 30 novel conserved miRNAs were identified in the liver of 
Atlantic salmon, of which ssa-miR-451 was the most abundant (Table S2 in 
Paper V). To the best of my knowledge, ssa-miR-451b has not been identified 
previously and to date only omy-miR-451a has been reported in rainbow trout 
eggs (Ma et al., 2012).  
With NGS, a new magnitude of variability in mature miRNA sequences has 
been observed. These sequence variants are referred to as isomiR. An isomiR 
is a multiple mature sequence that shows variations in one or several 
nucleotides compared with the reference miRNA sequence annotated in 
miRBase. In many cases, isomiRs of the miRNA* sequence (passenger strand) 
are also observed (Morin et al., 2008). In this thesis, a total of 43 new isomiRs 
not yet described were identified among the 22 miRNAs with the highest 
transcription rate in mature liver of Atlantic salmon, including two 3′isomiRs 
(Table S4 in Paper V). These isomiR variations might have a profound impact 
on target recognition and post-transcriptional mRNA degradation, especially 
when they are located in the seed region. For the other variations the effect 
85 
might not be as pronounced, but they are probably part of the fine-tuning of 
expression of the target miRNA (Brennecke et al., 2005). 
8.6.2 Evaluation for endogenous controls in miRNA qPCR 
Before the effect of miRNAs on gene regulation can be widely studied, a 
robust method for profiling the expression level of each miRNA in a sample is 
required. Ribosomal RNAs, small nuclear RNA (snRNA), small nucleolar 
RNAs and U6snRNA (RNU6B) have been frequently used as endogenous 
controls in qPCR studies of miRNA distribution. Criticisms have been 
expressed about these approaches (Li et al., 2012a). Identifying and using 
miRNAs as endogenous controls would be preferable, since they are exposed 
to the same treatment, are of similar size and exist in approximately similar 
quantities as target miRNAs. Identification of one or more specific endogenous 
control miRNAs is crucial for accurate comparison of miRNA expression. 
The expression of seven putative endogenous control genes (ssa-let-7a, ssa-
miR-16a, ssa-miR-16b, ssa-miR-194a, ssa-miR-22a, ssa-miR-22b, and ssa-
miR-27c) was evaluated as regards their tissue distribution and use as 
endogenous controls in microRNA expression studies. The increased 
expression of ssa-miR-16a in brain made it less suitable for tissue distribution 
studies and therefore only ssa-miR-27c was chosen as an endogenous control 
for the tissue studies in this thesis. However, ssa-miR-16a would work 
acceptably as an endogenous control in studies of liver and white muscle, 
among others. It has previously been used as an endogenous control in porcine 
blastocytes (Li et al., 2012a).  
Both ssa-miR-16a and ssa-miR-16b (Figure 13), as well as ssa-miR-22a and 
ssa-miR-22b, are isomiRs. As can be seen from the diagram, ssa-miR-16a and 
ssa-miR-16b only differ in one nucleotide in the second last position after 
3′end. However, this affects the size and position of the central loop, as well as 
minimum free energy (ΔG). Even if they have identical seed regions, Ye et al. 
(2008) showed that the location of the central loop is another important factor 
affecting the repression efficiency of gene regulation mediated by miRNAs. In 
Paper V, the transcription rate differed considerably between isomiRs in 
mature liver of Atlantic salmon, with 995 507 reads for ssa-miR-16a compared 
with 238 475 for ssa-miR-16b (Supplementary Table S4 in Paper V). The 
differences in transcription rate between the isomiRs ssa-mir-16a and ssa-miR-
16b, and between ssa-miR-22b and ssa-miR-22b, demonstrated using qPCR 
analysis in Paper IV agreed with the results from NGS data in Paper V. 
86 
 
Figure 13. Sequence of the mature isomiRs, loop structures and minimum free energy (ΔG) of the 
putative endogenous control genes ssa-miR-16a and ssa-miR-16b. 
8.6.3 Tissue distribution of conserved miRNA 
Quantifying miRNAs in different tissues is an important initial step to 
investigate functions of miRNAs. The tissue distribution of miRNAs provides 
baseline references to analyze variations in miRNA expression under various 
environmental and physiological conditions. 
A few of the miRNAs tested in this thesis, such as ssa-miR-22b, ssa-miR-
26b and ssa-miR-27c, showed ubiquitous expression in all tissues, which 
indicates that they can be linked to basic fundamental functions. Ramachandra 
et al. (2008) found that omy-miR-26a was evenly represented in all tissues. 
This agrees with the findings for ssa-miR-26b in Paper V, since ssa-miR-26b 
only differed in one base in the second last position from the 3′end compared 
with omy-miR-26a and otherwise they have identical seed regions. However, 
the difference observed in expression pattern between the isomiRs ssa-miR-16a 
and ssa-miR-16b in both Papers IV and V suggests this cannot be taken for 
granted. 
Most of the miRNAs tested in Paper IV were expressed in a tissue-specific 
manner, although some overlap in expression was seen. This agrees with 
findings in rodents, fruit fly (Drosophila sp.) and zebrafish (Mishima, 2012; 
Kloosterman & Plasterk, 2006). 
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9 Main findings and conclusions 
The main conclusion reached in this thesis is that it is possible to interact with 
the metabolism of lipids in farmed fish by addition of bioactive compounds. 
Lipoic acid, sesamin and episesamin showed more potent effects on gene 
expression than genistein. Lipoic acid, sesamin and episesamin also caused 
some changes in FAs, whereas genistein did not.  
This thesis presents an in-depth analysis of the expression of miRNAs in the 
liver of Atlantic salmon. Some of these miRNAs have been shown to be 
regulating transcription factors and genes involved in cholesterol and lipid 
homeostasis in mammals. These findings provide a basis for understanding the 
role of miRNAs in the regulation of lipid metabolism in teleost fish and for 
devising novel approaches to improve aquaculture production of healthy fish. 
Furthermore, miRNAs can be used as biomarkers or as tools in molecular 
manipulation.  
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10 Future perspectives 
Future studies should continue research within the new fields of transcriptional 
regulation, use of biomarkers and investigating the mechanisms of specific 
pathways in fatty acid biosynthesis. Such studies should include: 
 Verification of the most abundant miRNAs and isomiRs identified in liver 
from mature Atlantic salmon post-smoltification using quantitative RT-
PCR. 
  Since miRNAs exert their function by regulating target mRNAs, the 
identification of miRNA targets involved in lipid homeostasis is critical to 
understanding their role. Future experiments should focus on identification 
of miRNA targets and functional characterization of their response in vitro 
and in vivo using synthetic premiRs and antimiRs.  
 Deep sequencing miRNA profiling of different somatic tissues in fish post-
smoltification and exposed to changes in feed formulation from fish oil to 
vegetable oils. 
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